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THE GUEST HOUSE 
This being human is a guest house. 
Every morning a new arrival. 
A joy, a depression, a meanness, 
some momentary awareness comes 
as an unexpected visitor. 
Welcome and entertain them all! 
Even if they are a crowd of sorrows 
who violently sweep your house 
empty of its furniture, 
still, treat each guest honourably. 
He may be clearing you out 
for some new delight. 
The dark thought, the shame, the malice 
meet them at the door laughing and invite them in. 
Be grateful for whatever comes 
because each has been sent 
as a guide from beyond. 
 
 Jelaluddin Rumi (translated by Coleman Barks) 
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Abstract 
 
Acquired brain injury (ABI) and long-term neurological conditions (such as multiple sclerosis, 
Parkinson’s disease), are major causes of disability in the UK, and can lead to significant 
physical, cognitive, neuro-behavioural, psychological and social difficulties for sufferers. 
Individuals affected by an ABI or neurological conditions commonly report difficulties around 
emotional adjustment, reduced attention, mental control, and self-efficacy and their health-
related quality of life also often appears to be much reduced. Whilst conventional  neuro-
rehabilitation  has tended to address physical and cognitive impairments and deficits rather 
than psychological sequelae, recently a growing trend for more holistic approaches appears 
to have emerged (e.g., Wilson et al., 2000, 2013).  Amongst these approaches, mindfulness-
based interventions (collectively known as MBIs) have sought to address this gap in terms of 
therapeutic intervention. There is a growing body of research evidence pointing to the utility 
of MBIs in the rehabilitation and support of these populations in improving perceived quality 
of life and increasing self-management of these conditions. However, the research still 
remains limited and debate persists in terms of the conceptual and theoretical framework of 
mindfulness. 
The present study sought to evaluate the effectiveness of an adapted, short-form MBI group 
programme for a mixed population of patients (n = 22) currently offered in a local neuro-
rehabilitation service. A specific pre-post control group design was adopted in order to 
investigate whether the intervention produced improvements in mindfulness skills, and 
whether these would in turn lead to improvements in measures associated with self-efficacy 
and perceived quality of life. Results indicated participants completing the MBI group 
programme showed significantly higher mean scores across measures of mindfulness. The 
results also indicated that these improvements were predictive of improvements across self-
efficacy and quality of life measures, with large effect sizes observed. The findings would 
appear to support the research hypothesis that a suitably modified MBI is beneficial for a 
mixed ABI population. Findings, study limitations, clinical relevance and implications, as well 
as methodological and theoretical considerations and directions for future research are 
discussed in light of the main research questions. 
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1. Introduction  
 
1.1 Acquired Brain Injury (ABI) and neurological conditions: brief overview  
It is perhaps useful to provide an overview of the current understanding and definitions of 
Acquired Brain Injury (ABI hereafter) and neurological conditions and distinctions thereof in 
order to set the context of the present study more clearly, and to provide a rationale for the 
methodological paradigm selected to investigate the potential effectiveness of the MBI 
under evaluation.  
1.1.1 Acquired Brain Injury 
An ABI is defined as any brain injury sustained as a result of trauma (also known as 
Traumatic Brain Injury or TBI), stroke, cancer, infection or other insult, etc. which has 
occurred after birth rather than congenitally. For the purposes of the present study, the 
term TBI hereafter will be considered under the more general category of ABI. ABI is 
assumed to be an inclusive category that covers acute (i.e., rapid onset) brain injury of 
various causes, including: 
 Trauma (due to head injury or post-surgical damage) 
 Vascular accident (stroke or subarachnoid haemorrhage) 
 Cerebral anoxic injury 
 Toxic or metabolic insult (e.g., hypoglycaemia) 
 Infection (e.g., encephalitis, meningitis) or other inflammation (e.g., vasculitis) 
 Tumours 
 
The Defense Centers of Excellence describes TBI as “a blow or jolt to the head that disrupts 
the normal function of the brain. The severity of the TBI is determined at the time of the 
injury and may be classified as mild, moderate or severe.”(DVBIC, 2010).  Mild TBIs are the 
most common, and 80 – 90% of all TBIs are classified as mild. Of note is that the course of 
recovery, symptoms, and evidence-based treatments are different for mild versus moderate-
severe TBI. 
Common symptoms associated with a TBI are: 
12 
 
Physical: headache, sleep disturbances, dizziness, balance problems, nausea/vomiting, 
fatigue, visual disturbances, sensitivity to light, ringing in ears 
Cognitive: slowed thinking, poor concentration, memory problems, difficulty finding words 
Emotional: anxiety, depression, irritability, mood swings 
 
1.1.2 Neurological conditions 
In contrast, whilst not technically classified as ABI, long-term neurological and 
neurodegenerative conditions such as Multiple Sclerosis (MS hereafter) and Parkinson’s 
disease (PD hereafter) also tend to be diagnosed and treated within general neurology and 
neuro-rehabilitation services. Aside from the practical considerations, both MS and PD 
(among other rarer forms of neurological disorder) can be thought of as disorders where the 
brain and its functioning are in some way implicated and impaired.   
MS is a relatively rare condition of the central nervous system (brain and spinal cord) with 
onset typically occurring in early adulthood. Diagnosis usually occurs between 20-50 years of 
age, with the course of the disease typically characterised by episodes during which white 
matter within the brain and spinal cord becomes inflamed and subsequently damaged by 
the immune system. White matter represents around 60% of brain volume and consists 
mainly of myelinated axons. Areas of inflammation cause scarring and hardening (a process 
known as sclerosis) across multiple areas in the brain and spinal cord which damage the 
protective myelin sheath in which nerve axons are encased and protected.  
The condition is poorly understood due to the variability of clinical presentations and the 
relative frequency of episodes. These episodes may be asymptomatic in many individuals 
however symptoms can occur suddenly, followed by periods of good or complete recovery 
(relapsing-remitting MS). In others, symptoms may increase gradually and progressively over 
a longer period of time (progressive MS). It is estimated that around 80% of MS patients 
have the former type. The female-male ratio of the condition is 2:1. It is the most common 
disabling neurological condition among young adults. 
PD is defined as a chronic progressive neurodegenerative condition resulting from the 
depletion and death of dopamine-containing cells of the substantia nigra in the brain. There 
is no consistently reliable test that can distinguish PD from other conditions with similar 
clinical presentations, which can prove problematic for diagnosis. Classic symptom 
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presentations include bradykinesia, rigidity and tremor, however due to the implication of 
dopaminergic pathways, depression is a common associated difficulty, as well as autonomic 
disturbances and pain (which may develop as the condition progresses).  
1.1.3 Prevalence of ABI and neurological conditions 
Within the general population, ABI and neurological conditions account for a significant 
proportion of short- and long-term disability (Department of Health, 2005, National Audit 
Office, 2011). Point prevalence rates remain relatively high (see Table 1). Prognoses and 
typical recovery trajectories are difficult to determine, due to the heterogeneity and 
variability of onset, course and symptomatology of the injury or condition, as well as other 
factors such as age, gender, physical health, social and environmental factors. In the case of 
stroke, mortality rates have halved over the last 20 years (Stroke Association, 2012). With 
increasing numbers of survivors of ABI and neurological conditions (due in part to advances 
in medical research), an increasing demand on services to develop effective rehabilitation 
pathways and interventions would seem crucial in the maintenance of individuals’ quality of 
life, psychological well-being and functioning across all areas of their lives. 
 
Table 1. UK prevalence/incidence rates for ABI and neurological conditions. 
Condition Prevalence rate 
per 100,000 p.a. 
Incidence 
(new cases) 
per 100,000 
p.a. 
Approximate numbers 
(total) 
    
ABI:    
Stroke 139 (F) ; 178 (M)2 240 300,0002 
TBI 1,200 175 420,000 
Infection varies varies varies 
Tumours 201 73 9,4003 
    
Neurological:    
MS 100-1401 41 85,0001 
PD  100-1801 171 120,0001 
    
    
    
Source: 
1
Neurological Alliance (2003), 
2
Stroke Association (2013), 
3
Office of National Statistics (2013). 
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1.2 Psychological difficulties associated with ABI and neurological conditions  
It is apparent, then, that ABI, whether as a result of trauma (e.g., road traffic accidents) or 
organic/neurological in nature (e.g., encephalitis, cerebral tumour, MS, PD, stroke), is a 
major cause of disability in the UK. What also seems clear is that it can lead to significant 
physical, cognitive, neuro-behavioural and psychosocial difficulties. More specifically, 
individuals who have sustained an ABI or have developed a neurological condition 
commonly report complex and often chronic difficulties around emotional adjustment, 
reduced attention, mental control and self-efficacy (i.e., the ability to manage and cope with 
the impact of injury or condition on their general functioning, health and quality of life).  The 
literature is clear and abundant in this regard (e.g., Ponsford, 1995; Rosenthal et al., 1998; 
Deb, 1999; Steadman-Pare et al., 2001; Alderman, 2003; Turner-Stokes and Hassan, 2002a, 
2002b; Khan-Bourne and Brown, 2003; Williams et al., 2003; Fleminger and Worthington, 
2009), and there continues to be increasing qualitative research evidence which supports 
this view. 
Thus health-related quality of life (HRQOL hereafter) often appears to be much reduced 
among individuals with ABI and neurological conditions, and the incidence of psychological 
difficulties such as anxiety and depression is typically high within this population (e.g., 
Wellisch et al., 2002; Tyerman and King, 2004; Hackett et al., 2005). In the case of MS, 
mental health comorbidity appears to be under-reported (McGuigan and Hutchinson, 2006; 
Marrie et al., 2008). Various possible reasons for this are: a perceived sense of loss (loss of 
self-identity), the transition from a functioning to “non-functioning” status; the duration and 
severity of symptoms post-injury and uncertain prognosis (with lengthy or partial recovery 
trajectories in some cases, e.g., Dennison et al., 2009); the impact of physical, 
neuropsychological and cognitive impairments and perceived disability on functioning (in 
some cases, individuals remain unable to continue or return to work); and relationships. 
Recent literature (e.g., Uprichard, 2009; Rogan et al., 2013) has pointed to the contribution 
of avoidant coping styles strongly predicting and correlating with depressive symptoms and 
difficulties managing the emotional impact of ABI and subsequent levels of post-traumatic 
growth. 
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1.3 Approaches to the management and rehabilitation of ABI patients   
Given the nature of their onset and course, it is understandable that conventional 
rehabilitation for ABI and associated neurological conditions has tended to address the 
physical and cognitive impairments and deficits rather than the psychological sequelae of 
brain injury or neurological disorder. This is certainly still borne out and emphasised within 
clinical guidelines to an extent. Nevertheless, there has been a growing recognition to 
address psychological issues within this population. As a leading exponent in the field, 
Turner-Stokes (2001) has recognised the differing needs of individuals who may require 
different services across the rehabilitation pathway and has proposed a “slinky” model (see 
fig. 1). The model highlights the importance of providing flexibility to allow access services at 
any time during their recovery, as well as facilitating seamless transition between services. It 
describes a progression of rehabilitation goals from reducing impairment to enhancing 
participation. 
 
1.3.1 Current clinical guidelines: ABI 
The BSRM/RCP National Clinical Guidelines for rehabilitation following ABI (RCP, 2003) 
briefly highlight recommendations for psychological interventions: 
G128: “patients should be provided with access to individual and/or group psychological 
interventions for their emotional difficulties adapted to take into account individual 
neuropsychological deficits” (p. 45); 
G131: “patients should have access to specialist individual group neuropsycho-therapeutic 
interventions to facilitate long-term psychological, family and social adjustment, including 
sexual relationships. This need may not arise for many years post-injury.” (p. 45)  
The NICE long-term rehabilitation for stroke guidelines (NICE, 2013) reiterate the need for 
psychological input for stroke victims and their families, however recommend further 
research in this area to provide more robust evidence. The authors of the National Clinical 
Guidelines for stroke (ICSWP, 2012) recommend brief, structured psychological therapy for 
stroke patients experiencing depression, and highlight the necessity for relevant adaptations 
in respect of those with neurological conditions. Similarly, the authors of the BPS Briefing 
Paper for stroke (Kneebone et al., 2010), whilst recognising the utility of cognitive, 
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pharmacological and physical rehabilitation components, stress the need for a 
comprehensive, holistic model of care which incorporates the provision of psychological 
approaches.  
 
Fig. 1. The “slinky” model of the phases of rehabilitation (after Turner-Stokes, 2001). 
1.3.2 Current clinical guidelines: neurological conditions 
Other guidelines raise similar issues. The NICE guideline for PD (NCC-CC/NICE, 2006), for 
example, acknowledges depression as a particularly widespread difficulty amongst those 
with PD, and cites cross-sectional studies indicating depression affects around 40% of PD 
patients. However, the recommendations focus primarily on pharmacological treatment 
using antidepressant (and in some cases, antipsychotic) medication. A recent BPS Briefing 
Paper for PD (MacNiven and Gaskill, 2009) highlights the need for dedicated specialist 
clinical psychology and neuropsychology input and strongly recommends these as core 
services in PD management and rehabilitation. Furthermore, it states that quality of life 
issues are obvious in relation to reducing psychological distress and morbidity. It stresses 
that service provision needs to consider the chronic nature of PD and recognise the 
variability and diversity of individuals’ difficulties over the course of the condition. 
Consequently, services should follow a model of holistic assessment and treatment, and take 
account of the patient’s social context. 
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With regards to MS, current NICE guidelines (2003, although a recent scope consultation is 
expected to review and inform new guidance due in October 2014) provide a somewhat 
tentative and limited view of treatment options. Recommendation 152 (p.119) states that 
psychological intervention (CBT) should be considered but only as part of an overall 
programme of emotional management. It also highlights (Recommendation 155, p. 120) the 
need for psychologically-based treatment for MS sufferers presenting with ‘marked’ anxiety.  
Recent patient information produced by the MS Society (2012) mentions multi-modal 
therapy (including visualisation techniques, meditation and guided imagery) as a potentially 
beneficial intervention in MS rehabilitation, however cautions that research is still scarce in 
this area and the evidence base is not sufficiently robust at present to inform relevant 
recommendations for its applicability. 
Ostensibly, from a practical standpoint, there is a distinct emphasis in the clinical guidelines 
on physiotherapy, occupational therapy and cognitive assessments and interventions, as 
well as pharmacological treatments for psychological problems. However, whilst there is 
some recognition regarding the emotional aspects of injury and/or long-term conditions, 
these are often not highlighted as prominently, with the possibility of a potential impact on 
patients’ well-being and long-term outcomes.  
 
1.4 Recent developments in psychological approaches to neuro-rehabilitation  
1.4.1 The emergence of holistic models of rehabilitation 
However, over the last two decades or so, a growing trend for more holistic approaches to 
rehabilitation appears to have emerged (e.g., Wilson et al., 2000, 2002; Tyerman and King, 
2003). Holistic approaches argue for the necessity to integrate, rather than separate, the 
cognitive, social, emotional and functional aspects of neurological injury and the promotion 
of awareness, acceptance and understanding in the process of rehabilitation. Amongst these 
approaches, mindfulness-based interventions (collectively known as MBIs) have sought to 
address this void in terms of therapeutic intervention. MBI approaches form part of the so-
called “Third Wave” of behavioural therapies (including amongst others, Mindfulness-based 
Stress Reduction [MBSR], Mindfulness-based Cognitive Therapy [MBCT, Seagal, Teasdale and 
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Williams, 2002], Acceptance and Commitment Therapy [ACT, Hayes, 2004; Hayes et al., 
2006] and Dialectical Behaviour Therapy [DBT, Linehan, 1993; Dimeff and Koener, 2007]).  
These therapies are considered to sit within the broader cognitive-behavioural theoretical 
framework. Consequently, in the field of neurological rehabilitation, evidence of 
effectiveness comes from cognitive behaviour therapy (CBT) as a treatment modality that is 
useful not only in terms of symptom management, (e.g., fatigue), but also in reducing 
common psychological effects of chronic illness such as depression and anxiety, promoting 
coping strategies and adjustment, and globally improving quality of life and psychological 
well-being of these patients.  
1.4.2 Self-efficacy and the “Third Wave” of behavioural therapies 
Alongside this trend towards more holistic models, an increasing interest has also arisen for 
making sense of an individual’s injury or condition and the perceived changes to one’s 
identity as psychological dimensions, as considered in cognitive behaviour therapy (CBT 
hereafter) interventions. One of the psychological mechanisms through which CBT 
interventions have demonstrated their effectiveness is in relation to self-efficacy. Self-
efficacy can be conceptualised as the individual’s appraisal of the extent to which he/she has 
the capabilities required to organize and realize actions needed to obtain planned goals in a 
specific domain (Bandura, 1997). Its promotion has been demonstrated to be useful for the 
management of chronic diseases, such as MS, and appears positively linked to psychological 
adjustment and to improvements in quality of life (Thomas et al., 2006; Mohr et al., 2012; 
Graziano et al., 2013). 
The key differentiating principle between the second and third generation  or “wave” of 
behavioural interventions is that the earlier wave of traditional cognitive and/or cognitive-
behavioural  therapy (CBT) approaches focussed directly on the objective of altering 
psychological events (e.g., thoughts, beliefs, perceptions, schemas) through a variety of 
techniques (such as cognitive restructuring), whereas  by contrast,  the third wave aims to 
change the function of these events and the individual’s relationship to psychological and 
contextual experiences rather than the events or experiences themselves or the content 
therein. A secondary objective is not necessarily to eradicate symptoms entirely, rather to 
embrace and accept negative or aversive experiences with a view to managing symptoms in 
a manner which facilitates and ultimately promotes self-efficacy and well-being. 
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It is within this context that the work of Barbara Wilson and colleagues at the Oliver Zangwill 
Centre has sought to adopt a model of rehabilitation incorporating holistic principles, 
developing a programme including both individual and group therapeutic intervention 
alongside others.   One of the more recent additions to the programme has been the 
inclusion of Compassion-Focused Therapy (CFT hereafter: Gilbert, 2010) approaches which 
incorporate elements of mindfulness-based work  in addressing commonly reported issues 
and challenges around self-criticism, rumination and post-injury adjustment  within this 
population (Wilson et al., 2013). 
In summary, if the premise of MBIs is on facilitating functional change, it could therefore be 
inferred that they may have a particular utility for supporting individuals with ABI and with 
long-term neurological conditions in adjusting to life post-injury and post-diagnosis, as well 
as re-engaging in living more meaningfully, in spite of their neurocognitive and physical 
impairment and the accompanying sense of uncertainty about their future. The 
management of psychological problems would therefore appear to be pivotal for individuals 
living with ABI and neurological conditions given how their chronic nature can not only 
hamper quality of life, but also bring about broader social, economic, interpersonal and 
psychological consequences due to reduced social, community and occupational functioning 
(Cicerone et al., 2008; Kangas and McDonald, 2011). 
 
1.5 History and development of mindfulness meditation practice: adaptations and 
applications to healthcare settings  
Whilst it is beyond the scope of the present study to describe in any great detail the history 
and development of mindfulness or meditation approaches and their clinical applications, it 
is nevertheless worth noting the influential impact of the work of Jon Kabat-Zinn in the 
secularization and adaptation of what essentially are considered Buddhist or Eastern 
philosophical traditions, as well as mindfulness’ place within the therapeutic framework (i.e., 
as part of the aforementioned “Third Wave” of cognitive-behavioural paradigms). The 
emergence and development of MBIs in medical settings as an adjunct or alternative to 
conventional treatments for chronic health conditions was in large part conceived, 
developed and promoted by Kabat-Zinn at the University of Massachusetts Medical School. 
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1.5.1 Mindfulness-based Stress Reduction (MBSR) 
Thus the Mindfulness-based Stress Reduction (MBSR) approach is based primarily on the 
work of Kabat-Zinn (1982, 1992). A student of zen and vipassana meditation as well as yoga, 
Kabat-Zinn recognised how due to its specific focus on attentional practices, meditation 
potentially lent itself well to adaptation within a medical setting and in particular with 
clinical populations struggling with long-term conditions. In a similar vein to traditional 
meditation practice, MBSR emphasises the cultivation and development of non-judgmental 
present-moment awareness and acceptance of perceptible sensory, emotional, 
psychological and cognitive events and processes. Simply put, MBSR encourages the 
principle of “being here now” and refraining from self-critical appraisals of one’s experience, 
accepting this experience “as it is” rather than “as it should be”.  As such, it is a non-goal 
oriented intervention with a distinct focus on process rather than outcome. Typically an 8-
session, 16-hour group-based intervention (numbers tend to be relatively small) initially 
designed for patients with chronic pain, MBSR has now been widely implemented in a 
variety of medical and psychiatric settings and across a range of populations. 
 
1.6 Mindfulness-based interventions: conceptual and theoretical overview 
 
1.6.1 The concept of “mindfulness” : definitions and operationalization  
The practice of mindfulness is a method of attention regulation which originated in Eastern 
(predominantly Buddhist) contemplative and meditation traditions (Cullen, 2011). The term 
itself is an English translation of the Pali (the Buddhist language of psychology) word sati. 
Sati connotes three central concepts of awareness, attention and remembering (Germer, 
2013). Mindfulness has been described as: 
 “paying attention in a particular way: on purpose, in the present moment, and non-
judgmentally.” (Kabat-Zinn, 1994, p. 4) 
The majority of the psychological and neuroscience literature concerning mindfulness 
adopts the definition as proposed by Kabat-Zinn, albeit with some variation of emphasis. 
Kabat-Zinn was instrumental in translating more traditional, Buddhist approaches of 
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meditation practices into the secular context of Western general healthcare and 
psychological interventions (Kabat-Zinn et al., 1985, 1992; Kabat-Zinn, 2011). Thus, within 
this psychological context, mindfulness is conceptualised as non-judgmental awareness of 
the present moment, and is broadly thought to involve a particular attitude or stance in 
attentional focus. 
Whilst differences of opinion do exist amongst clinicians and researchers between the more 
traditional, Buddhist perspectives of mindfulness and its “modern” psychological 
adaptations, there appears to be widespread agreement that a clearly formulated method of 
mental training – commonly referred to as meditation – is necessary for the development 
and enhancement of levels of mindfulness (Chiesa and Malinowski, 2011). It is therefore 
generally assumed that meditation practice facilitates increased levels of mindfulness. 
However, debate persists within the mindfulness community regarding its conceptualisation, 
and some subtle yet key differences remain between the principal models of mindfulness as 
regards a unitary definition of the construct and the purported mechanisms by which it 
operates. In recent years, four main models (amongst others) appear to have emerged, each 
of which merit further description in the light of the population under investigation and the 
specific psychological issues with which they present.  
 
1.7 Models of mindfulness  
1.7.1 Bishop et al. (2004): the 2-component model 
Bishop et al. (2004) have proposed a 2-component stepwise model of mindfulness, 
comprising a component of initial self-regulation of attention elicited through an awareness 
to current and immediate experience (observing and attending to the changing field of 
thoughts, feelings and sensations from moment to moment). The second component, which 
Bishop and colleagues postulate occurs as a consequence of this attentional practice, is the 
adoption of a particular orientation towards one’s experience in the present moment. This 
orientation consists of a stance characterised by curiosity, openness and acceptance.  In 
short, this model of mindfulness can be defined as a process of regulating attention in order 
to engender a quality of non-elaborative and non-judgmental awareness to current 
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experience. What follows from this initial practice is a process of insight into the nature of 
one’s mind and the adoption of a de-centred perspective. 
1.7.2 Shapiro et al. (2006): the IAA model 
Similarly, Shapiro et al. (2006) also addressed the question of how MBIs actually operate 
rather than the effectiveness of these interventions, and proposed three essential 
components (or axioms) of mindfulness within the framework of a model also known as the 
IAA Model. The three main components are: (i) Intention; (ii) Attention and (iii) Attitude. 
Shapiro and colleagues relate these three axioms to Kabat-Zinn’s definition where (i) 
equates to “on purpose”, (ii) equates to “paying attention” and (iii) to “in a particular way”. 
They emphasise that these are not separate processes or stages per se, rather they are 
interwoven within a single cyclical or recursive process, and may occur simultaneously (fig.  
2): 
(i) Intention 
The role of intention, as the IAA Model postulates, is linked to the origins of meditative 
practice as conceptualised within Buddhist traditions, for which intention equates to an 
extent with what is defined as enlightenment and compassion. An earlier study (Shapiro, 
1992) found that as meditators continued to practice, their intentions shifted along a 
continuum from self-regulation to self-exploration, eventually leading to self-liberation (i.e., 
the experience of transcending the sense of being a separate self, a central tenet in the 
Buddhist meditative tradition). Intention can also be conceptualised as the reason or 
motivation for practising, and as such is considered a core component of mindfulness within 
the IAA Model, since this is crucial to an understanding of the process as a whole;  
 
     Intention 
 
     Attention     Attitude 
Fig. 2. The IAA Model of Mindfulness (Shapiro et al., 2006). 
 
 t ti  
Attention    Attitude 
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(ii) Attention 
Within the psychology literature, attention has been posited as crucial to the healing 
process. This is not a recent theoretical consideration. Gestalt therapy emphasises present-
moment awareness: Perls stated that “attention in and of itself is curative” (Perls, 1969, 
p.16). Attention is also an important element within CBT theory, which emphasises the 
capacity to observe, and therefore attend to, internal and external behaviours; 
(iii) Attitude 
The IAA Model, similarly to Kabat-Zinn (1990), defines attitude as the qualities an individual 
brings to attention, and has been conceptualised as the attitudinal foundations of 
mindfulness. The model posits that individuals can learn to attend to their own internal and 
external experiences, without evaluation or interpretation. This in turn will foster a practice 
of acceptance, kindness and openness even when what is occurring in one’s field of 
experience is contrary to deeply held wishes or expectations. Mindfulness training thus 
allows one to be open to each experience as it arises, but to also allow it to pass away. 
Bringing an intentional attitude of patience, compassion and non-striving is thought to 
facilitate an ability to refrain from continually striving for pleasant experiences, or indeed to 
push aversive ones away. This component appears largely in line with Bishop and colleagues’ 
concept of “orientation to experience”. 
1.7.3 The Buddhist Psychological Model (BPM; Grabovac et al., 2011) 
In a bid to offer a model of mindfulness which sufficiently explains, describes and 
encapsulates the mechanisms and processes of change operating within the individual, 
Grabovac et al. (2011) have proposed a psychological model derived from more purist 
Buddhist traditions (the Buddhist Psychological Model, or BPM, fig. 3). In general terms, the 
BPM describes three main characteristics of mental activity which mindfulness practice 
targets and which appear crucial in the development of well-being and symptom alleviation 
or reduction:  
(i) Impermanence: sensory and mental events are transient in nature and occur in a 
continuous stream of consciousness; 
(ii) Suffering: this arises as a result of habitual reactions to the affective responses 
of these events; 
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(iii) Not-self: sensory and mental events do not constitute or contain any discrete, 
durable, static entity which one could define as a self. 
As such, mindfulness as proposed by the BPM is defined as the moment-by-moment 
observation of, and subsequent insight (via attention regulation practices) into these three 
characteristics. 
 
Fig. 3.The Buddhist Psychological Model of Mindfulness (Grabovac et al., 2011). 
1.7.4 The Liverpool Mindfulness Model (Malinowski, 2012) 
The Liverpool Mindfulness Model (LMM hereafter; Malinowski, 2012; fig. 4) is a more recent 
attempt to conceptualise and define the core components of mindfulness and to provide a 
framework for directing future research. As such, it is broadly consistent with the other 
interactional models of mindfulness in that it emphasises the central role of attentional 
skills, and structures the process of mindfulness into five main levels, namely: 
Motivational factors (level 1) which determine whether or how an individual engages in the 
mind training (level 2). It is postulated that this regular engagement in mindfulness practice 
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further facilitates and refines mental core processes (level 3) via the interaction of 
attentional skills and cognitive and emotional regulation. Improvements in these core 
processes result in an altered and more balanced mental stance or attitude (level 4), 
characterised by non-judgmental awareness, which in turn results in positive outcomes (level 
5) across physical, mental and behavioural domains. 
Similarly to other phenomenological accounts of mindfulness (Shapiro et al., 2006, Lutz et 
al., 2008), the LMM suggests that attentional control skills underpin the development of 
emotional regulation skills. The training of these attentional skills is also thought to underpin 
cognitive and emotional flexibility, facilitating the capacity to maintain a non-judging 
awareness of one’s own thoughts, feelings and experiences generally. Consequently, this 
facilitates the quality of one’s behaviour and leads to positive outcomes in terms of health 
and well-being (Chiesa and Malinowski, 2011; Malinowski, 2013).  
 
Fig. 4. The Liverpool Mindfulness Model (after Malinowksi, 2012). 
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Two specific attentional practices – Focused Attention (FA) and Open Monitoring (OM) – 
postulated by Lutz et al. (2008), whilst conceptually considered distinct from one another, 
are present in all forms of mindfulness training to varying degrees. The FA component is 
cultivated and developed initially to facilitate awareness of present-moment mental states, 
whereas the OM component consists of moment-to-moment attentional focus to anything 
occurring in the person’s experience. With increasing experience , it is thought that OM 
practice relies progressively less on FA over time and can eventually be sustained without 
focussing on any explicit object (e.g., one’s breathing). 
In summary, these fundamental principles are captured by common psychological 
definitions of mindfulness which emphasise the fostering and development of  attentional 
abilities combined with a specific, non-evaluative, non-critical attitude toward the different 
mental  (or physical) experiences which may arise at any given moment. 
 
1.8 Mechanisms of mindfulness: how mindfulness operates beneficially in 
psychological terms  
Whilst the main accounts elucidated above appear largely consistent with one another with 
respect to identifying the core psychological facets of mindfulness, and the collective body 
of mindfulness literature has grown exponentially in recent years, there remains a relative 
paucity of theoretical reviews which integrate the existing mindfulness research into a 
comprehensive theoretical and conceptual framework with a view to identifying the 
mechanisms and processes of mindfulness. In a recent article, Hölzel et al. (2011) describe 
the processes through which mindfulness operates beneficially on the individual by referring 
to five essential stages: 
1. Attention regulation: defined as sustaining attention on a chosen stimulus or object 
(usually external) and when noticing that the mind has become distracted, returning 
the attention to the object; 
2. Body awareness:  during this process, the focus is usually an object of internal 
experience (e.g., breathing, emotions, or other physiological sensations) and is 
linked to the process of focussing one’s attention to the present moment; 
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3. Emotional regulation – reappraisal: approaching and re-construing ongoing 
emotional reactions differently and in a more positive, meaningful or benign light; 
4. Emotional regulation – exposure, extinction and reconsolidation:  this describes the 
process by which mindfulness practitioners expose themselves to whatever is 
present in their field of awareness (both internal and external events), allowing 
themselves to be affected by the experience, but refraining from engaging in 
internal reactivity towards it. The aim is to embrace and accept rather than avert 
distressing or unpleasant emotions with a view to gaining insight into the transient 
nature of such emotions or events which eventually pass away and are replaced by a 
sense of well-being or security; 
5. Change in perspective on the self: in line with traditional Buddhist philosophical 
notions, the self is perceived as a product of an ongoing mental or psychological 
process rather than a permanent, static entity. The Buddhist view posits that 
identification with this static sense of self is the origin of psychological distress 
(Olendzki, 2010). Mindfulness practice is thought to foster the development of 
meta-awareness1 which facilitates a detachment from one’s identification with this 
static sense of self, thereby leading to a “deconstruction of the self” and eventual 
“self-liberation” (as reported by Shapiro, 1992). This also appears to be consistent 
with other theoretical notions of “de-centering” as proposed by Bishop et al. (2004). 
1.8.1 Mindfulness and mental modes of processing 
In a similar vein, Williams (2010) has drawn on evolutionary theory to postulate that 
emotions can be understood as automatic, transient processes and reactions which are 
sensitive to environmental contingencies. As such, emotions can be “switched on” or 
“switched off” in response to these contingencies. Williams has proposed that the failure to 
adequately “switch off” emotions is a result of the activation of mental representations of 
past, present and future created independently of these contingencies. According to 
Williams, these representations or “simulations” occur within the sphere of two distinct 
mental modes in which the mind operates and in which information is processed:  a “doing” 
mode (verbal, conceptual) and a “being” mode (sensory, perceptual; Williams, 2008). It is 
posited that psychopathology arises from an excessive use of the “doing” mode in 
suppressing, avoiding or elaborating emotional expression. 
                                                          
1
 This can be defined as “awareness of awareness” itself. 
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Fig. 5. The two modes of mind (after Williams, 2010). 
Fig. 5 is intended as a schematic representation of the relative probability of the two modes 
in which the mind operates, as proposed by Williams: the conceptual (language-based) 
processing mode versus sensory-perceptual processing mode. In every waking moment one 
receives stimuli from internal and external sources such as sights, sounds, touch, smell and 
taste.  However, these are generally filtered out or processed in favour of devoting one’s 
attention in conceptual mode, i.e. thinking, planning, daydreaming, analysing, remembering, 
comparing, judging etc. Attentional training within mindfulness cultivates the ability to shift 
modes (from “doing” to “being”) as an essential first step to being able to hold all experience 
(both conceptual and sensory) within a wider awareness which itself is neither merely 
sensory nor conceptual. This practice enables the individual to focus attention to both the 
objects themselves but also to their reactions to them and their associated implications.  
1.8.2 The processes by which mindfulness works: examples 
Within mindfulness training, one of the specific meditation practices, the Body Scan, is an 
example of how this attentional focus is thought to facilitate the mode of “being” and 
consequently enable the individual to relate differently to mental states (fig. 6). The 
attentional processes within the Body Scan consist of an attention engagement-
disengagement cycle, which is repeated around 50 times. Each cycle entails 4 intentional 
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components: (1) shifting attention from one region of the body to another; (2) engaging 
attention at this site; (3) remaining in this place to discover and explore sensations 
experienced here; (4) disengaging attention before repeating (1) – shifting to the next part 
of the body. During this practice, two additional meta-intentions must be held in working 
memory: (1) to notice the mind wandering and return attention to the intended focus; and 
(2) to explore sensations – whilst acknowledging the mind wandering – adopting an attitude 
of friendly enquiry, curiosity and compassion rather than analysis, comparison or judgment.  
 
Fig. 6. Attentional processes during the Body Scan practice (after Williams, 2010). 
In line with Williams’ proposed account of the psychological processes involved in 
mindfulness, one of the central premises of the BPM (Grabovac et al., 2011) is that 
awareness occurs in relation to sensory impressions (i.e., physical sensations) or mental 
events (e.g., a memory, thought or emotion). This awareness is transient in nature: it lasts 
momentarily before passing away, with discrete sense impressions and mental events arising 
and ceasing in a rapid, continuous stream or flow (fig. 7). However, the BPM suggests that an 
individual’s attentional resources are limited therefore one can only be aware of one object 
at a time. 
According to the BPM, concomitant to the awareness of an object, an individual experiences 
any one of three categories of “feeling tone”. This is not strictly equivalent to an emotion, 
rather a spontaneous affective response to the awareness of a sense impression or mental 
event.  These responses are habitual and typically involve a desire to pursue pleasant 
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feelings whilst avoiding unpleasant ones (in Buddhist terminology, these are denoted as 
attachment and aversion, respectively). Contrary to widely-held assumptions regarding 
these processes as reactions to an object of awareness, the BPM proposes that attachment 
and aversion occur in response to the feeling state itself as opposed to the object.   
 
Fig. 7. The process of moment-by-moment awareness (after Grabovac et al., 2011). 
These initial feeling tones or states are also succeeded by mental events with their own 
concomitant feelings. This in turn brings about a process of mental proliferation during 
which attachment or aversion occurs in reaction to the feelings associated with these mental 
events, and is experienced in the form of additional mental events. The implication of this 
process is that at times the proliferation may occur in a recursive fashion, with subsequent 
mental events apparently being quite far removed from the initial sense impression. As a 
result, one becomes unaware of the patterns of attachment and aversion and how they 
bring about mental proliferation, thereby ensuring the maintenance of the entire, habitual 
process. Thus for an MS sufferer, an initial sense of hopelessness about their prognosis 
might in turn lead to seemingly unconnected thoughts ranging from anger to denial.   
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1.8.3 The BPM perspective  
As mentioned earlier, the BPM posits that all sensory impressions and mental events are 
considered to share three common characteristics: impermanence, suffering (which includes 
psychopathology or symptomatology) and not-self. These are essentially Buddhist terms of 
reference. It is the habitual reactions (in the form of attachment or aversion) to feeling 
states and associated mental proliferation that are the source of suffering (fig. 8). The BPM 
thus proposes that mindfulness practice (in the form of attention regulation resulting in 
sustained attention on an object) brings about an interruption and reduction in mental 
proliferation. 
 
 
Fig.8. The 3 characteristics of sensory impressions/cognitions and associated mental events 
(after Grabovac et al., 2011). 
 
Alongside this, when an individual permits the emergence and subsequent dissipation of 
sensory and mental events, without engaging in cognitive processing and elaboration (as a 
result of attachment or aversion), this engenders an increased sense of well-being. These 
events will continue to be experienced as pleasant, unpleasant or neutral. However, since 
mental proliferation will have been momentarily attenuated or interrupted, it is 
hypothesised that suffering does not occur.   
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This process is facilitated by encouraging an individual to develop an awareness of thoughts, 
feelings and bodily sensations as they arise, but gently allowing them to “step back” from 
these experiences without judging them or attempting to eradicate them (fig. 9).  This can 
be done through a variety of practices, but most commonly involves focussing one’s 
attention on one’s breath. Over time, this practice fosters the capacity to be able to identify 
maladaptive patterns of processing sooner, thus reducing the propensity for emotional 
dysregulation or mental proliferation (this has often been described as “thoughts spiralling 
out of control”, for example). 
 
Fig. 9.The mechanisms by which regulation affects moment-by-moment awareness in 
mindfulness practice (after Grabovac et al., 2011). 
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1.8.4 Proposed alternative mechanisms for the operationalization of MBIs in psychological 
well-being 
The aforementioned models of mindfulness are not the only explanations which have been 
proposed in terms of putative mechanisms or processes for its operationalization.  
Alternative proposed mechanisms for MBIs include: a perceptual re-distancing leading to 
increased tolerance and acceptance of somatic pain and/or maladaptive thinking or 
emotional processes; greater exposure to thoughts and feelings leading to reduced 
responses to fear or anxiety; greater self-awareness and self-motivation and efficacy leading 
to improvements in psychosocial coping strategies; reduced autonomic arousal leading to 
increased levels of relaxation; and on a biological level, modification of immune and 
neuroendocrine system pathways (Baer, 2003; Ludwig and Kabat-Zinn, 2008, Compare et al., 
2012).  
Similarly to Shapiro et al. (2006), Carmody et al. (2009) make reference to the concept of 
reperceiving which they define as involving a fundamental shift in perceptual perspective 
that enables a mindfulness practitioner to adopt a stance of observation in relation to 
moment-to-moment experience. This also facilitates recognition of the fleeting nature of 
thoughts, emotions and physical sensations. The authors describe this in similar terms to the 
Western psychological constructs of decentering and defusion (a term commonly used in 
ACT literature).  
 
1.9 A review of the research literature concerning MBIs  
1.9.1 The context of mindfulness research and its clinical applications with ABI 
During 2012 and 2013, over 500 scientific articles on mindfulness were published, more than 
the total number of articles published between 1980 and 2000 (Shonin et al., 2013a, also see 
fig. 10 for a graphical representation of this increase in mindfulness research studies). There 
has been a veritable explosion in terms of mindfulness research undertaken which appears 
to have accompanied this surge of interest in the field and its perceived clinical applications 
and utility. Recent research findings have begun to suggest that Mindfulness-based 
Interventions (MBIs hereafter) may offer effective treatments for an increasingly broad 
range of psychological and somatic disorders and illnesses (Chiesa and Serretti, 2011; 
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Fjorback et al., 2011). Clinicians’ views of MBIs also seem largely favourable to its purported 
benefits: a recent survey (Mental Health Foundation, 2010) found that 75% of GPs in the UK 
considered mindfulness to be beneficial for patients with mental health difficulties.  
Qualitative research would also appear to support the acceptability of MBIs amongst 
patients and service users (Williams et al., 2011, Shonin et al., 2013a). 
 
Fig. 10. Results obtained from a search of the term ‘mindfulness’ in the abstract and 
keywords of the ISI Web of Knowledge database. The search was limited to publications with 
English language abstracts. Figure prepared by David S. Black, Institute for Prevention 
Research, Keck School of Medicine, University of Southern California (2014).  
 
However, whilst there appears to be a growing evidence base for the utility of MBIs across 
diverse clinical settings, a relative lack of research in certain areas, and in particular, the area 
of Acquired Brain Injury (ABI hereafter) and chronic neurological conditions, remains.  The 
reasons for this dearth may be manifold, not least since historically ABI and neurological 
conditions present specific challenges to services as regards variable prognoses and recovery 
35 
 
trajectories, short-term and long-term rehabilitation needs, with traditional approaches 
involving physical or pharmacological treatments generally being preferred over potentially 
less cost-effective interventions. However, given the difficulties these populations commonly 
report with emotional and psychological adjustment, psychosocial issues and quality of life, 
the principles and practices underpinning MBIs would appear to lend themselves well as a 
viable therapeutic  intervention supporting positive long-term outcomes. 
 
1.10  Recent neuroscientific and neuropsychological evidence for mindfulness  
From a neuroscience perspective, there is increasing evidence in support of the capacity for 
experientially dependent neuroplasticity in both the developing and injured brain (see Green 
and Turner, 2010, for a recent research digest). Whilst still limited in scope, more recent 
research considering the beneficial effects of MBIs on the healthy adult brain has yielded 
some interesting findings, with potentially important clinical implications within the field of 
neuro-rehabilitation. Neuroimaging studies employing functional magnetic resonance 
imaging (fMRI) and structural methods have begun to provide strong confirmatory evidence 
for MBIs engendering neuroplastic changes, as well as   further elucidating the neural 
correlates of specific mental and behavioural gains as a result of meditation practice.  
In what is considered a seminal study, Lazar et al. (2005) detected increases in cortical 
thickness within the anterior insula in experienced meditators. These findings were 
replicated subsequently by Hölzel et al. (2008), who further noted dose-dependent increases 
in grey matter density in the right anterior insula, left inferior temporal gyrus and right 
hippocampal regions. In a study by Farb et al. (2010) which evaluated an MBSR programme, 
participants demonstrated a significant difference in neural activity during experimentally 
induced sadness (exposure to a film) pre- and post-intervention, despite reporting the same 
degree of sadness prior to and following exposure to the stimulus.  
The literature would therefore suggest that the activity of mindfulness may be (i) located in 
specific brain regions; and (ii) that regular practice results in the development of neural 
circuits in these regions. Thus, in line with the hypothesis proposed by Williams (2010), 
mindfulness facilitates shifts in regulation strategies from brain regions supporting cognitive-
affective representations or “simulations” of the self towards those involved in viscero-
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somatic information processing – in short, a shift from “doing” to “being” mode. Other 
studies evaluating the effects of MBIs have also reported specific patterns of neural 
activation in brain regions typically associated with sustained attention (Brefczynski-Lewis et 
al., 2007), interoceptive awareness (Critchley, 2004) and focus on endogenous body states 
(such as attention and monitoring of breathing; Vestergaard-Poulsen et al., 2009). 
Encouraging recent evidence in terms of MBIs bringing about structural changes with 
neurological populations has also been provided by Pickut et al. (2013). In this longitudinal 
randomized controlled trial (RCT hereafter) using voxel based morphometry (VBM), 
significant changes in grey matter density involving the hippocampus and right amygdala 
were observed in a sample of 14 PD patients compared to a group receiving usual care (UC) 
alone. This suggests changes in neural networks and brain regions which have been posited 
to play an important role in PD and which appear to be implicated in the functional networks 
mediating the benefits of MBIs. 
 
1.11  A literature review regarding  the effectiveness of MBIs and ABI/neurological patient 
populations – evidence and future developments  
It is generally accepted that there has also been an exponentially increasing evidence base 
for the success of MBIs across a range of medical, psychiatric and psychological disorders 
and conditions (Baer, 2003; 2006). MBIs appear to be particularly effective in reducing 
anxiety and depression symptomatology (Carmody and Baer, 2008; Hofmann et al., 2010). In 
addition, the literature supports the view that MBIs may be effective for panic disorders, 
binge eating disorders, and substance abuse; and they have even been deemed promising 
practices by the US Defense Centers of Excellence (Moore et al., 2011).  More recent 
evidence supports their effectiveness with a number of chronic health conditions (e.g., 
chronic pain, anxiety, cancer – e.g., Speca et al., 2000). Grossman et al.’s (2004) meta-
analysis examined the impact of MBSR on a range of health samples and found moderate to 
large (d = 0.40 – 0.90) effect sizes. However, very little research has been conducted with 
regard to its effectiveness with ABI or neurological patient populations. The few studies that 
have examined this question have tended to be pilot studies with small sample sizes, 
thereby rendering results difficult to generalize. Nevertheless, there are some notable 
findings from these studies which merit some consideration. 
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 1.11.1 MBIs and Multiple Sclerosis 
 
In a randomized controlled trial of MS patients, Grossman et al. (2010) provided evidence of 
MBIs improving quality of life and associated measures of psychological well-being for at 
least 8 months post-intervention. Interestingly, baseline neuropsychological status was not 
related to outcome. Simpson et al. (2014) have recently published a systematic review of 
MBIs with MS clinical populations, however only cite 3 studies included in the final analysis: 
Mills and Allen (2000); Grossman et al. (2010); and Tavee et al. (2011). The review reports 
encouraging results as regards improvements in measures related to HRQOL, anxiety, 
depression and fatigue (with effect sizes ranging from d = 0.39 to 0.86), however the authors 
note that the very small number of studies analysed, their variable methodological quality 
and the heterogeneity of the MBIs delivered in each study are not especially conducive in 
drawing firm conclusions regarding the clinical utility or benefit of MBIs for MS. Recently 
published research by Senders et al. (2014), which evaluated the relationship between trait 
mindfulness and perceived stress, coping (self-efficacy) and resilience in 119 MS patients 
found that greater trait mindfulness was significantly associated with decreased 
psychological stress, better coping skills, increased resilience, and higher quality of life. After 
controlling for confounders, results indicated that mindfulness accounted for 25% of the 
variation in perceived stress scores and 44%of the variation in resilience scores. These 
results would appear to further support mindfulness training to enhance psychological 
resilience and improve well-being for those living with MS. 
 
1.11.2 MBIs and Parkinson’s disease 
 
As regards PD, in a qualitative study by Fitzpatrick et al. (2010) examining an 8-week MBCT 
course, results revealed PD patients perceived benefits associated with changes in coping 
styles and consolidation of coping skills as a result of group MBI. A recently published study 
protocol by Advocat et al. (2013) for a 6-week MBI lifestyle programme aimed at adults with 
PD aims to employ a mixed-methods, randomised 2-group control design together with 
qualitative in-depth interviews with participants. The authors highlight that research in this 
area is still in its infancy. 
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1.11.3 MBIs and ABI 
Johansson et al. (2012) have provided further evidence that MBSR may be a promising non-
pharmacological intervention for mental fatigue post-TBI or stroke. Azulay et al. (2013) 
found significant effects on measures relating to quality of life (d = 0.43) and perceived self-
efficacy (d = 0.50). They concluded that the MBSR programme can be adapted for individuals 
with mild traumatic brain injury (mTBI). Furthermore, the improvements observed in these 
areas may be attributed to treatment directed at encouraging awareness and acceptance, 
thereby minimising the catastrophic appraisal of symptoms commonly associated with mTBI 
and chronic disability.  
In a recent systematic review concerning stroke conducted by Lawrence et al. (2013), 4 
studies involving 160 participants were reviewed. Three papers reported MBIs delivered to 
groups (including Johansson et al., 2012, as mentioned earlier); one paper reported an MBI 
which was delivered on a one-to-one basis. Results indicated a positive trend in favour of the 
benefits of MBIs across a range of psychological, physiological, and psychosocial outcomes 
including anxiety, depression, mental fatigue, blood pressure, perceived health, and quality 
of life. Similarly, in a systematic review examining yoga and mindfulness in stroke 
rehabilitation, Lazaridou et al. (2013) identified a study by Hofer et al. (2014) which noted 
significant clinical improvements following an integrative, “mindfulness-enhanced” neuro-
psychotherapeutic  rehabilitation programme for stroke victims. 
Recent studies have found clinically meaningful improvements in ABI populations. More 
promising preliminary evidence for MBI as a potentially useful intervention in this regard has 
been indicated by Bédard et al. (2003). In this pilot study, participants with MTBI (or 
moderate TBI) were enrolled in a 12-week group intervention (manualized and based on 
Kabat-Zinn et al.’s MBSR programme and Kolb’s *1984+ experiential learning paradigm). The 
emphasis of this programme was on present-moment awareness, acceptance via insight 
meditation, breathing exercises, guided visualisation techniques and group discussion. 
Individuals were encouraged to view their TBI-related disabilities from a fresh perspective 
facilitated by approaching their circumstances via acceptance in order to move forward with 
their life. Treatment gains were shown to have been maintained after one year (Bédard et 
al., 2005).  
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Three studies that altogether examined 32 individuals found positive effects of 
meditation/MBI on individuals with ABI, and merit particular consideration. One study 
(Azulay et al., 2013) examined the effects of an MBSR programme (adapted from Kabat-
Zinn’s MBSR programme) for a group of 22 individuals with persisting post-concussion 
symptoms with mild TBI who were concurrently participating in a TBI rehabilitation 
programme, had relatively intact memory, and were at least three months post-injury. They 
found improvements in perceived quality of life (d = 0.43), perceived self-efficacy (d = 0.50), 
working memory, and regulation of attention after 10 weeks of group-meditation-based 
stress reduction modified to specifically meet cognitive challenges using a standardized (i.e., 
manualized) curriculum. However, there were no effects of treatment on neurobehavioral 
symptoms.  They noted that practising acceptance (which is considered a central tenet of 
mindfulness-based work) could be an important factor for individuals with TBI in particular 
with a view to help mitigate negative perceptions of self that may be associated with chronic 
symptoms (Azulay et al., 2013).  
 
A pilot study with 10 participants (with a comparison group of three patients who did not 
complete the treatment) examined the impact of a 12-week MBSR group intervention, also 
standardized and with a manual, that focused on insight meditation, breathing exercises, 
guided visualization, and an emphasis on psychological well-being through awareness and 
acceptance (Bédard et al., 2003). This patient population had mild to moderate TBI, had 
completed rehabilitation, was considered to have good insight, and did not present with co-
occurring psychological health conditions (70% were women). Participants reported 
improved quality of life and improved aspects of depression (specifically in the cognitive-
affective area). In a follow-up study, seven of the participants were evaluated one year post-
intervention (Bédard et al., 2005). These participants reported improved mental health as 
well as continued reduction in depressive symptoms. 
 
In contrast, a larger, randomized controlled trial (McMillan et al., 2002), which consisted of 
145 individuals with various severities of TBI who exhibited problems with attention on 
neuropsychological testing or who reported difficulties with attention in daily life three 
months to one year post-injury, examined the impact of brief mindfulness training for 
attention problems after TBI. This brief training consisted of a group intervention across five 
45-minute sessions over four weeks, with regular practice encouraged between sessions 
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using audiotapes. Participants were followed up 12 months after the intervention. Data was 
collected in relation to the amount of mindfulness practice the participants engaged in 
during the 12 months following the training.  
 
Although the published article did not report the amount of practice, it did report no 
significant differences within these variables through any of the groups. Importantly, and 
interestingly, the authors found no significant differences in cognitive functioning, mood, or 
symptoms, leading to the conclusion that brief exposure to mindfulness meditation “could 
not be recommended as a treatment technique for traumatic brain injury cases” 
(p.117). However, they noted that further research was needed and highlighted that the 
amount of therapist contact was low, possibly diluting the potential impact of the training on 
outcomes. 
 
1.11.4 MBIs in non-clinical populations: relevance for ABI 
 
While there appears to be a relative paucity of evidence regarding the effectiveness of MBIs 
in the treatment of ABI, there is other research suggesting that meditation/MBIs have a 
positive impact on some common symptoms of ABI. Although these studies excluded 
individuals with psychological or neurological disorders, their findings suggest that MBIs may 
have positive effects across cognitive and emotional domains: 
 Attention: Studies have found that meditation positively impacts one’s ability to sustain 
focused attention and cognitive efficiency (Kozasa et al., 2012). For example, one 
recent study (Lutz et al., 2009) examined intensive meditation training (for 10-12 hours 
daily over three months) and found that it improved participants’ ability to sustain 
attention over time; 
 Memory and Executive Functions: Even brief mindfulness practices have been found to 
have positive effects in terms of memory and executive functioning. Zeidan et al. 
(2010) found that novices in mindfulness practice who spent twenty minutes daily for 
four days in meditation training recorded significantly lower scores of fatigue, anxiety, 
and improved working memory, visuo-spatial processing, and executive functioning as 
compared to a control group whose members listened to a recorded book instead; 
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 Depression: In a sample of participants who had a history of at least one previous 
episode of major depression and had been in recovery for at least eight weeks, both 
guided meditation and loving kindness (also known as metta) meditation practices 
were associated with aspects of depression (Barnhofer et al., 2010). For example, those 
who tended to engage in ruminative thinking (cf. the BPM concept of mental 
proliferation) responded well to deep breathing, whereas those who did not often 
ruminate responded better to loving kindness meditation. Additionally, mindfulness 
has been linked to a greater ability to deal with negative emotions, which could 
decrease the development of depressive symptoms (Barnhofer et al., 2011); 
 Mood:  Long-term meditation practice has been associated with greater emotional 
stability and an improved ability to accept emotional states as well as awareness of 
moment-to-moment experiences (Taylor et al., 2011); 
 Pain: Mindfulness-based practice has also been found to attenuate pain, irrespective of 
what form of mindfulness is practised (Gard et al., 2011). In this particular study, 
mindfulness practice appeared to reduce the unpleasant experiences of pain by 22% 
through decreasing cognitive control and increasing sensory processing in the brain 
(i.e., facilitating and developing the “being” mode over the “doing” mode). 
 
1.12  Cautions and criticisms concerning the utility of MBIs in neurological populations 
 
Debate persists as to the utility of MBIs in the field of neuro-rehabilitation. Certain clinicians 
appear to suggest that the ability of individuals with ABI to learn to meditate and/or benefit 
from meditation might depend on the severity of the ABI and the presence of specific 
neurocognitive and neurobehavioral deficits. Theoretically speaking, the location and extent 
of the injury, as well as time since injury and level of recovery, could also impact one’s ability 
to meditate or sustain a level of dispositional mindfulness (including regular practice). This 
may also hold to an extent for those living with long-term neurological conditions where the 
onset, course and variability of pathology and symptomatology may be key factors in 
treatment gains and outcomes as well as individuals’ beliefs or attitudes towards them. 
A critical appraisal of this is also necessary in light of the heterogeneity of this clinical 
population. The question remains as to how far clinical improvements and/or quality of life 
can be attributed to mindfulness given the variability of recovery trajectories in individuals 
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and other potential moderating variables (such as age, gender, type of injury, time since 
injury, socio-economic circumstances, relationship status, occupational status, associated 
physical health issues, medication, patients’ perceived level of support from others, etc.). 
It is perhaps important to acknowledge that the studies mentioned above used 
modifications to typical MBSR programmes to help those with ABI perform meditation 
successfully (McMillan et al., 2002; Bédard et al., 2003, 2005; Azulay et al., 2013). For 
example, one study adapted the MBSR programme by focusing on increasing attention skills, 
increasing awareness of internal and external experiences, and adopting a non-judgmental, 
accepting attitude throughout the practice. 
 
Some within the meditation community believe that the central concepts of mindfulness 
practices would fit well with the symptoms and needs of individuals with ABI and their 
recovery and rehabilitation. Opponents of this view argue that the nature of an injury to the 
brain may prove too great an obstacle for traditional practices that require a level of 
sustained attention and focused cognitive activity due to the location of the injury. 
Additionally, a third contingent have proposed that it may be a little of both viewpoints, 
depending on the nature and severity of the ABI, the time since the injury, and where the 
individual currently resides in the rehabilitation process. 
 1.13 Summary of key points 
 
 There is insufficient research on MBIs and ABI and neurological conditions; very few 
studies have examined the impact of meditation or MBIs in these populations, thus 
highlighting the need for more research in order to gain a better understanding of its 
potential role and impact, if any; 
 At present, the few studies that have been published report some encouraging but 
mixed results, and caution should be exerted in interpreting these findings until further 
research has been published and methodological issues are considered; 
 Some research suggests that meditation and MBIs may hold some benefits in the 
domains of attention, memory, executive functioning, depression, mood changes, and 
emotional reactivity in non-ABI populations. The neuroscience literature also appears 
to be providing evidence for the benefits of MBIs on a neurobiological level. 
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1.14 Rationale for this research  
In conclusion, it is clear that ABI and neurological populations typically experience a range of 
cognitive, physical and psychological difficulties post-injury or diagnosis, and that this may 
continue for a considerable length of time. There is a growing body of research evidence 
suggesting the usefulness of MBIs in the rehabilitation and support of these patients in 
improving their perceived quality of life, as well as potentially reducing symptoms of 
psychological distress associated with adjustment to ABI or chronic conditions. However, the 
evidence still remains somewhat limited, both in terms of the number of studies conducted 
to date, and the lack of controlled trials. As such, this was considered an area worth 
exploring further. One of the aims of the present study was to add to this growing body of 
evidence by evaluating an intervention which is currently already being offered to patients in 
a neuro-rehabilitation service. 
 
The study sought to employ a quantitative methodological design (using standardized, 
validated self-report questionnaires) in order to evaluate the efficacy of a specifically 
adapted MBI (based on an MBSR programme) in question for a mixed (i.e. with diverse 
clinical presentations) ABI sample, including MS, PD and other patients with neurological 
conditions. Specifically, it consisted of an experimental, randomly generated group pretest-
post-test design. It was hypothesised that patients who received the mindfulness group 
intervention would show greater improvements on measures associated with increased 
psychological wellbeing, improved emotional regulation and a sense of managing with 
difficulties after injury as a result of the mindfulness techniques introduced as opposed to a 
waitlist control. It was also hypothesised that this in turn would lead to improvements on 
measures of health-related quality of life (HRQOL).  
 
Furthermore, if findings were shown to be significant in terms of improving clinical 
outcomes, this may have important financial implications for the potential application of 
similar, adapted forms of MBI across services in light of the current constraints on resources 
in order to manage high volumes of referrals to services. It was hypothesised that the 
present study would consolidate and provide further supporting evidence for the efficacy of 
MBI in the management and rehabilitation of individuals with ABI and neurological 
conditions in terms of facilitating a reduction in psychological symptoms commonly 
associated with these.  
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1.15 Research questions and hypotheses 
The two main aims of the study can be defined as follows: 
(1) The first aim of the study was to evaluate how effective an adapted (i.e., specifically 
tailored, short-form) mindfulness-based group intervention was in facilitating 
mindfulness skills in a mixed patient population who have suffered an ABI or have a 
diagnosed neurological condition. Two different types of outcome measures for 
mindfulness will be used to capture a broad range of mindfulness skills relating to 
present-moment awareness, attention, and non-judgmental appraisals of physical, 
mental and sensory experiences. 
(2) The second aim of the study concerned the question whether an improvement in 
participants' mindfulness skills would also lead to improvements in their self-efficacy 
as well as self-rated quality of life. More specifically, as a result of improved 
mindfulness skills, will individuals at the end of the intervention report improvements 
in their ability to regulate their emotions, tolerate unpleasant or distressing 
experiences, respond to these in a more equanimous manner and feel capable of 
managing the psychological impact of their injury or condition better? Will there also 
be improvements in their perceived quality of life across physical health, social, 
occupational and cognitive domains? 
The study will employ a special pre- post control group design (see Methods for details) to 
evaluate the benefits of the MBI programme. The two aims above were translated into the 
following between- and within-groups comparisons representing the two intervention 
hypotheses of the study: 
(1) The adapted MBI under investigation will lead to increases in mindfulness, self-
efficacy and quality of life, and so the intervention group will report higher means on 
relevant outcomes measures at the end of the MBI training in comparison to a wait-
list control group; 
(2) The MBI training will lead to significant improvements in mindfulness skills which, in 
turn, will produce beneficial effects on self-efficacy and quality of life. It is therefore 
predicted that the means on relevant outcome measures will be higher at the end of 
the MBI training relative to the means at baseline assessment. 
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2. Methods 
 
2.1 Study design 
 
The present study employed a quantitative design in order to evaluate the efficacy of the 
adapted mindfulness-based intervention in question for an ABI sample (individuals with an 
ABI or diagnosis of a neurological condition). Specifically, it consisted of an experimental, 
randomly generated control group pretest-posttest design, consisting of three groups of 
participants. Participants were randomised either to an intervention group or a group who 
had been placed on a waiting list for the mindfulness programme at a later stage. This group 
of participants would therefore serve as controls and initially would not receive the 
intervention until the first two groups had completed the intervention. Therefore all groups 
would receive the intervention, but at different time points. The third group was assessed at 
a later stage, and received the intervention approximately 10 weeks after the initial group. 
At the time of analysis, post-intervention data was not available for this last group, and 
therefore has not been included in the results. Fig. 11 may assist in clarifying the study 
design.  
 
The independent variable was the adapted MBI in question. The dependent variables of 
interest were: changes in mindfulness (Freiburg Mindfulness Inventory, FMI; Mindful 
Attention Awareness Scale, MAAS); self-efficacy (Mindfulness-based Self-Efficacy Scale-
Revised, MSES-R) and health-related quality of life (Perceived Quality of Life Scale, PQoL). 
Further details concerning these variables and associated outcome measures are outlined 
later in this chapter. 
 
2.2 Participants 
 
A total of 22 individuals consented to participating in the study. Participants were all current 
adult patients within Hertfordshire Neurological Service and receiving treatment as part of 
their rehabilitation following ABI or a diagnosis of a neurological condition.  
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Fig.11.Schematic representation of the study design. Dotted arrows indicate planned 
comparisons or pooling of participants.  
 
2.3 Selection criteria 
 
2.3.1 Principal inclusion criteria  
 
The principal inclusion criteria for eligibility and participation in the study are outlined 
below: 
 
1. Individuals who had sustained an ABI (e.g. stroke, traumatic brain injury, viral infection, 
tumour, etc.) or had a diagnosis of a chronic neurological condition (e.g. MS, PD) ; 
2. Individuals who had been identified by their healthcare team or treating clinician as 
potentially benefiting from a mindfulness-based psychological intervention as part of their 
ongoing care and rehabilitation package; 
3. Individuals aged 18 years and above (the service in question does not have an upper age 
limit for patients); 
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4. Individuals who possessed an adequate level of physical and cognitive functioning as 
determined either by standardised measures or clinical assessment by qualified staff prior to 
referral to the group; 
5. Individuals possessing a good level of fluency in, and comprehension of, the English 
language. 
 
2.3.2 Principal exclusion criteria  
 
Individuals who were considered to present with any or all of the following issues were 
deemed unsuitable and therefore excluded from the study: 
1. Significant comorbidity including a current diagnosis of psychiatric disorder; 
2. Significant cognitive impairment (as regards memory and processing ability); 
3. Significant physical impairment, disability or mobility issues which would impact adversely 
on the ability to attend sessions or remain seated for lengthy periods of time ; 
4. Severely limited or reduced fluency in, or comprehension of, written and spoken English. 
 
2.4 Recruitment 
 
2.4.1 Identification and selection of potential participants 
 
All potential participants were identified via a referral database and associated waiting list 
for the group intervention managed within Hertfordshire Neurological Service (Hertfordshire 
Community NHS Trust). Participants were recruited from the Acquired Brain Injury Team 
referrals list within this database. Referral details provided in the referral forms made to 
Hertfordshire Neurological Service had previously been screened for suitability by the clinical 
psychologists or other members of the healthcare team working within the service. If 
deemed suitable, the individual in question was approached for consent for their personal 
information to be accessed as part of the research study. The length of time that individuals 
had been waiting between referral to the group and initial contact ranged from 
approximately 5 to 12 months. 
 
Potential participants were initially approached concerning the study by telephone. A total 
of 46 patients from the mindfulness group referral and waiting list were contacted in 
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relation to the study. Two attempts at contacting individuals were made. Those individuals 
who did not respond to either of these two attempts were considered as not wishing to 
participate. However, a number of individuals who did not wish to participate in the study 
did express a desire to attend the mindfulness group. As mentioned earlier, potential 
participants had already been identified via their healthcare team as possibly benefiting 
from the mindfulness-based intervention, therefore were aware of being placed on the 
waiting list for the group intervention. This would have taken place after discussing this 
option with their healthcare team or relevant treating clinician. 
 
In the case of some patients, brief screening psychometrics would have been administered 
to determine the individuals’ baseline level of cognitive or neuropsychological functioning. 
These consisted of standard neuropsychological assessments which would have been 
conducted as a matter of protocol in terms of their package of rehabilitation care (e.g., for 
ABI patients) prior to individuals having been identified as suitable candidates for the MBI 
group, and referred accordingly via their clinicians. These may have included a selection of 
WAIS-IV (Wechsler, 2008) subtests focussing on attention as well as more specific 
neuropsychological measures relating to memory, information processing and cognitive 
impairment. These assessments would not have necessarily been undertaken as a definitive 
screening tool for the MBI, but may have informed clinical decisions concerning the 
suitability of the individual for referral to the mindfulness meditation group.  
An important consideration in respect of this evaluation study was to the potential role of 
confounding variables as alternative explanations for outcomes. In the case of ABI and 
neurological conditions, this may relate to the extent to which improvements of a clinical or 
psychological nature as mentioned previously can be attributed to the intervention alone or 
indeed to natural rates of recovery (and hence improved adjustment/psychological well-
being) among individuals living with these long-term conditions or injury.  Where possible, 
additional factors to consider were the heterogeneity of the sample in terms of precise ABI 
sustained or neurological diagnosis (e.g., whether the classification of MS was primary 
progressive or relapsing-remitting), severity of the injury, time since injury or course of 
disease, as well as other potential moderators such as age, gender, occupational and marital 
status, and level of education across the sample. 
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2.5 Description of intervention 
The intervention in question adopted a suitably modified (i.e., non-manualized) version of 
the traditional MBSR programme originally developed by Kabat-Zinn (1982, 1992). Standard 
MBSR programmes consist of 8 weekly sessions of 2 hours each including a day-long session 
of practice which usually takes place after the sixth session. Historically and currently, the 
programme under investigation in the present study has been delivered over 4 weeks and 
comprises 4 sessions of an hour each, with an emphasis on daily between-session practice 
and feedback/discussion of the same during sessions (for a similar study employing an 
adapted, short-form mindfulness programme, see McMillan et al., 2002). In a review of 
contact hours and psychological outcome measures, Carmody and Baer (2009) suggested 
that adaptations involving less “class” time may be beneficial for populations for whom 
reduction of psychological distress is an important goal and for whom longer time 
commitment may be a barrier to their access, ability or willingness to participate. 
 
2.5.1 Content of sessions 
 
Whilst not exhaustive, the following is intended as a descriptive guide to the content of each 
intervention session, in chronological order (see Appendix 1 for detailed session-by-session 
information and materials provided to participants): 
Session 1: Introductions, aim of the group (focus on teaching mindfulness meditation skills), 
facilitator’s personal experience of meditation/mindfulness practice; rules of the group, 
confidentiality, respecting others’ opinions, invitation to record mindfulness meditation 
practice, general housekeeping rules; individual introductions, timetable of group; guidelines 
on how to meditate, meditation diary, articles on mindfulness and Jon Kabat-Zinn’s work; 
definitions of mindfulness meditation and theoretical framework for MBI; meditation as 
fundamentally an experiential process; 2 x sets of guided mindfulness meditation practice 
and feedback to group; 
Session 2: Introductions, feedback from and reflections on maintaining a mindfulness diary, 
1 x guided mindfulness practice; feedback/reflections on this; applying mindfulness to 
everyday life – aims in applying mindfulness practice in relation to difficult experiences e.g. 
physical pain, anxious or critical thoughts, negative cognitions, awareness of 
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distracting/negative thoughts and “letting go”; goals re: applying mindful thinking in daily 
life and continuation of daily mindfulness meditation practice; 
Session 3: Introductions, reflections on maintaining the mindfulness diary, 1 x guided 
mindfulness practice; feedback/reflections on this; application of mindfulness to everyday 
life re: experiential avoidance and unhelpful coping strategies; goals re: applying mindful 
thinking in daily life and continuation of daily mindfulness meditation practice; 
Session 4: Introductions, reflections on mindfulness diary, 1 x guided mindfulness practice; 
feedback/reflections on this; learning to take care of oneself in relation to rumination and 
avoidance and learning to alter one’s response to negative events rather than attempting to 
alter the events in themselves. 
Participants were also supplied with paper-based mindfulness diary sheets in which to 
record their practice (see Appendix 2 for an example of the diary).  
 
2.6 Measures 
2.6.1 Rationale for selected measures 
The following empirically validated and standardized measures were suggested and 
discussed with a view to capturing both the process and impact of the intervention under 
evaluation in terms of the predicted reduction of individuals’ psychological symptoms and 
the enhancement of their psychological well-being in relation to measures of mindfulness, as 
defined by the presence of increased dispositional interoceptive awareness and attentional 
focus. In addition, it was suggested that a measure capturing key constructs associated with 
self-efficacy, e.g., acceptance, equanimity, distress tolerance, emotional regulation and 
adjustment (amongst others) would also be useful in order to examine possible effects of 
increased dispositional mindfulness on the sample in question, given the propensity for 
patients’ difficulties in these areas, as indicated and suggested by the literature.  
Some thought was given to the respective length of questionnaires and their wording. 
Despite not including participants with gross cognitive impairment, particular attention was 
also paid to the cognitive demands the questionnaires might entail. Further discussion 
concerned their possible uses or adaptations for the purposes of this study. Outcome 
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measures were administered in paper form pre- and post-intervention for all groups in the 
presence of the researchers so as to facilitate any explanations of items. All measures were 
administered on site during a single sitting. Where this was not possible, arrangements were 
made to do this at the participant's home. In some cases, measures were forwarded by post 
and participants contacted to ensure their receipt and return.  
The measures employed in the present study can be found in Appendix 3 in the order in 
which they are presented below. The final measures selected were as follows and were 
administered to participants in the order in which they are presented in the following 
section. 
 
2.6.2 Primary outcome measures: measures of trait and dispositional mindfulness 
 
Freiburg Mindfulness Inventory (FMI; Walach et al., 2006) 
The FMI is a useful, valid and reliable questionnaire for measuring mindfulness, and is one of 
the most widely used measures in MBI research. It is suitable for all generalised clinical 
contexts, and does not assume any particular knowledge or endorsement of the Buddhist or 
Eastern religious or spiritual background of mindfulness. The 14 items on the FMI cover all 
aspects of mindfulness. All items are scored to obtain a single summary score; one item is 
reverse-scored. The FMI takes around 5 minutes to complete. 
Mindful Attention Awareness Scale (MAAS; Brown and Ryan, 2003) 
The MAAS is a 15-item scale designed to assess a core characteristic of dispositional 
mindfulness; that is, open or receptive awareness of, and attention to, present-moment 
experiences. The scale possesses strong psychometric properties and has been validated 
with a variety of clinical and non-clinical samples. The trait MAAS has shown excellent 
psychometric properties. Factor analyses with undergraduate, community and nationally 
sampled adult, and adult cancer populations have confirmed a single factor scale structure 
(Brown and Ryan, 2003; Carlson and Brown, 2005). Internal consistency levels (Cronbach’s 
alpha) generally range from .80 to .90. The MAAS has demonstrated high test-retest 
reliability, discriminant and convergent validity, known-groups validity, and criterion validity. 
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Correlational, quasi-experimental, and laboratory studies indicate that the MAAS taps into a 
unique quality of consciousness that is related to, and predictive of, a variety of self-
regulation and well-being constructs. A recent study combining both quantitative and 
qualitative data (Dobkin, 2008) found that the MAAS was a potentially useful process 
measure in assessing changes in mindfulness. All items are scored and added together to 
obtain a total (no items are reversed). The overall score is derived from computing the mean 
of the 15 item scores. The MAAS takes around 10 minutes to complete. Normative 
information on the trait MAAS is available for both community adults and university 
students: community adults (4 independent samples): N = 436; MAAS M = 4.20, SD = .69; 
university students (14 independent samples): N = 2277; MAAS M = 3.83, SD = .70. 
 
2.6.3 Secondary outcome measures: measures of self-efficacy 
Mindfulness–based Self-Efficacy Scale-Revised (MSES-R; Francis and Cayoun, 2011) 
The MSES was originally developed as a 35-item self-report questionnaire constructed to 
measure the change in levels of self-efficacy before, during, and following MBI programmes 
(specifically Mindfulness-based Cognitive Therapy [MBCT]). The MSES-R is a shorter (22-
item) version that emerged from psychometric data collected from a community sample (N 
= 521). It is a valid and reliable measure, with a six-factor structure (namely: equanimity, 
emotional regulation, social skills, distress tolerance, taking responsibility and interpersonal 
effectiveness). It is perhaps useful to further elaborate on the respective subscales: 
 
 Emotion Regulation (subscale 1) relates to an involuntary or subconscious 
emotional response that is well modulated and falls within the expected normal 
range of responses; 
 Equanimity (subscale 2) relates to the ability to normalise difficulties and prevent 
reactivity (e.g., not being overly critical or judgmental of oneself); 
 Social Skills (subscale 3) relates to social abilities in the broader sphere of 
interaction with others; 
 Distress Tolerance (subscale 4) also relates to emotional responses, but taps into 
voluntary responses, which inhibit avoidance of experiential intolerance or 
discomfort (e.g., the capacity to “sit with” distressing experiences); 
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 Taking Responsibility (subscale 5) relates to clarity of interpersonal boundaries and 
locus of control in terms of one’s difficulties; 
 Interpersonal Effectiveness (subscale 6) relates to the ability to connect with others 
within the intimate sphere of relationships.  
 
The above factors have all been identified in the literature as important skills that may 
improve with mindfulness. The MSES-R is used for both clinical and research purposes, with 
the advantage of measuring the consequences, rather than just the processes, of 
mindfulness training. It is estimated that the MSES-R takes around 10-15 minutes to 
complete. An online version is available, however for the purposes of the study, was deemed 
potentially unsuitable for use by some participants. 
 
Test-retest reliability for the MSES-R is very good (r = .88, N = 100, p < .01; shared variance 
for the 22-item scale was 78%). Internal consistency is indicated as reliably high (Cronbach’s 
alpha = .86). The MSES-R possesses a good inverse relationship with the Depression Anxiety 
and Stress-Short Form measure (DASS21, Lovibond and Lovibond, 1995) and has shown good 
discriminant validity. The scale discriminates well between scorers who report having a 
mental illness from those who do not. Convergent validity is consistently in the good range 
with other mindfulness measures such as the Kentucky Inventory of Mindfulness Skills 
(KIMS, Baer, Smith & Allen, 2004), Five Facet Mindfulness Questionnaire (FFMQ, Baer et al., 
2006), FMI and MAAS. Overall, the MSES-R can be considered to possess good construct 
validity and is considered a reliable measure. 
 
2.6.4 Secondary outcome measures: measures of Health-related quality of life (HRQoL) 
Perceived Quality of Life Scale (PQoL; Patrick et al., 1988, 2008) 
The PQoL was initially developed as a cognitive appraisal of an individual’s life satisfaction 
after intensive medical care. However, it has been applied to adults with chronic 
neurological disability including stroke and TBI (Cicerone and Azulay, 2007), and was 
therefore considered particularly appropriate for the population in the present study. This 
was due in part to its brevity and focus on social and physical health aspects. Consisting of 
19 main items, it measures the extent to which an individual is satisfied with their 
functioning on an 11-point scale (i.e., 0-10) ranging from extremely dissatisfied/unhappy to 
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extremely satisfied/happy. An additional single item (item 20) addresses an individual’s 
global level of happiness (“How happy are you?”) and is used to examine convergent validity 
within the instrument.  
The overall score for the PQoL is obtained by computing the mean or median of the 19 main 
item scores. Subscale scores of physical, social and cognitive health satisfaction may be used 
in further analysis. One item (item 7, relating to diet) does not appear to fall into any factor 
and it is advised that this be used on its own. For convergent validity purposes, the overall 
PQoL score can be correlated with item 20 (the happiness rating). The Pearson’s or ICC 
correlation coefficient should exceed 0.70. 
2.6.5 Feedback evaluation forms 
In addition to the above measures, it was considered potentially useful to supply 
participants with a brief feedback evaluation form in order to encourage patients to provide 
qualitative data in terms of the perceived benefits, the practical and logistical aspects of the 
MBI group programme, as well as comments or suggestions for future improvements or 
changes to the structure or delivery of the MBI group (see Appendix 4 for a copy of the 
evaluation form). This is standard practice across all group-based interventions within the 
local service in which the present research was conducted. The evaluation form consisted of 
10 items focussing on participants’ views regarding the length of the intervention and 
individual sessions, the content and environment of the sessions and attendees’ perceptions 
of how beneficial the group programme had been in terms of increased knowledge of 
mindfulness as well as the acquisition of mindfulness-based skills and across psychological 
symptoms (low mood, anxiety, anger). A space was provided at the end for further 
comments.  
 
 
2.7 Procedure 
 
2.7.1 Obtaining consent 
Following initial contact as outlined above, all participants received a written participant 
information sheet outlining the nature, aims and expected timescale of the study, including 
all procedures, any potential risks and benefits involved (see Appendix 5). Potential 
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participants who had indicated an interest in the research were given a maximum of 10 
working days following receipt of the relevant information sheet in which to decide whether 
they wished to take part in the study or not. They were also encouraged to contact the 
researchers if they wished to seek clarification on any of the information supplied to them 
concerning the study. A separate participant consent form (see Appendix 6) was drafted to 
explain that participation was entirely voluntary and that participants had the right to 
withdraw from the study at any time, without having to provide a reason for this. 
Participants were expected to sign this form and this took place in person with the 
researchers. A letter informing individuals’ GP of their participation was also prepared 
(Appendix 7). 
 
2.7.2 Randomisation procedure 
 
The flowchart in Fig. 11 may assist in clarifying the study design and randomisation 
procedure. Participants were assigned to one of three groups according to a computer 
generated randomization list (computerized random numbers). As such, participants were 
randomly assigned with a 1:1 allocation ratio following permuted block design procedures, 
using block sizes of four. No stratification criteria were used. The allocation sequence was 
generated by an independent administrator not directly involved in this project after 
baseline measures had been collected, thus ensuring that recruiters were kept blind to the 
allocation of each participant. The allocation sequence was password protected and only 
accessible by the administrator. 
 
2.7.3 Intervention setting and delivery 
 
The intervention was delivered over four consecutive sessions, lasting approximately one 
hour each. Sessions took place once a week, therefore the total length of the intervention 
was approximately one month. The intervention took place in a clinical space within one of 
two main sites in Hertfordshire Neurological Service (one covering the North and East of the 
county, the other the South and West; the present study was conducted in the South and 
West). This is largely dependent on where patients live and takes into account distance they 
may be required to travel. The group was facilitated by an experienced clinical psychologist 
with extensive clinical expertise in mindfulness-based therapeutic techniques and training. 
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The facilitator was blinded to the participants’ identities and randomization procedure. 
Three groups were run consecutively over a period of 14 weeks from January to April 2014. 
 
2.7.4 Administration of measures 
It was proposed that the questionnaires would be administered at 3 or 4 key points during 
the process: 
 Baseline assessment 
1. A set of self-report measures as detailed previously was administered initially to all 
participants in the first two groups who had agreed to take part in the study; 
2. The same set of measures was administered to participants in a third waitlist control 
group. This took place after group 1 had completed the intervention; 
 Post-intervention 
3. These measures were administered again after participants had completed the group 
intervention (i.e., after session 4) within a timeframe ranging from 2-4 weeks of this date; 
4. It was proposed that the same questionnaires would be administered approximately 3 
months after the last session of each group intervention (follow-up). However, due to 
logistical issues and timing constraints, this was not possible.  
 
It was expected that each set of measures would take approximately 30-45 minutes to 
administer, for a total of 180 minutes (3 hours). In some cases, participants were offered the 
opportunity of a short break within the allotted assessment appointment where they had 
indicated any difficulties with concentration levels or fatigue. No assessment lasted more 
than 50 minutes. All measures were administered face-to-face in consulting rooms located 
within the rehabilitation facility. 
 
 
2.8 Determining the sample size 
 
As highlighted previously, a recently published study (Johansson et al., 2012) suggested 
evidence for considerable improvement in symptomatology and some reduction in 
depression and anxiety of neurological patients following participating in an MBSR 
(Mindfulness-Based Stress Reduction) group. Based on this study, a power calculation was 
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conducted to establish the sample size. Assuming that the MBI training would lead to a 
substantial improvement corresponding to a strong effect size (i.e. Cohen’s d = .80) a sample 
size of N = 42 would detect a mean difference between the intervention (n = 21) and the 
control group (n = 21) with a power of .80 and an alpha level of 5% (one-tailed). With an 
increase in the effect size the demand for the sample size would go down and so a sensitivity 
analysis was conducted in addition, as it was unlikely to recruit that many participants. The 
reason for this restriction to the recruitment of participants was down to the fact that the 
sample size was dependent on the waiting list which had accrued at the time the study 
commenced as well as the number of individuals agreeing to take part in the study. The 
figure below displays the result of a sensitivity analysis in relation the effect size d and the 
sample size required to detect it with a power of .80 and the alpha error (5%). 
 
Fig. 12. G*Power 3 (Faul et al., 2007) result of a sensitivity analysis for the study. 
 
According to the sensitivity analysis a sample size of around 26 would suffice to detect a 
large effect size of around 1. 
 
2.9 Statistical Analyses 
 
Descriptive statistics and suitable graphical data analysis were conducted to explore the 
distribution of the outcome measures for anomalies and normality. Mean differences 
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between groups were tested for statistical significance using the t-test for independent 
groups and with one-tailed p-values set at 5%, whereas mean differences from baseline to 
the end point were tested for statistical significance using the dependent samples t-test. 
An intention to treat (ITT) analysis was also carried out to deal with any dropouts during the 
course of the intervention. Further analysis would involve an investigation of the individual 
change scores in the treatment group with a view to identifying important predictors of 
clinically significant change or, conversely, to identifying circumstances that may have 
prevented participants in benefiting from the intervention. This was achieved through a 
correlational analysis using Spearman’s rank correlation as the sample size was rather small. 
 
2.10 Ethical Considerations  
2.10.1 Psychological and emotional distress 
Because some of the practices in mindfulness-based interventions encourage an awareness 
of one's feelings or thoughts, some thought was given to potential upset or distress in 
participants. One consideration was that re-assessment measures may have highlighted the 
emotional and psychological impact of the brain injury or neurological condition on 
participants. However, all measures administered in the study were validated and 
standardised. Participants were informed that in such an event, they would be supported by 
qualified professionals within the service in managing any difficult emotions.  
 
The intervention took place in a clinical setting which aimed to provide a safe and containing 
space for this to occur and for participants to discuss and process these feelings. This space 
is regularly used for group-based work. Participants were encouraged to be able to request 
individual consultation and/or debriefing with professionals outside of the intervention 
where they identified this as beneficial. Between sessions, there was regular liaison with 
participants' care team to ensure this support if offered in cases where this had been 
indicated or felt necessary. In addition, several procedures were put in place to reduce any 
further risk to participants: 
1. Participants were provided with detailed information regarding the aim and nature of the 
study in order to provide informed consent. It was reiterated that participation was entirely 
voluntary and that they could withdraw from the study at any time, without explanation; 
59 
 
2. Participants were informed that their decision to participate or withdraw from the study 
would not affect any concurrent care management or treatment; 
3. The group was facilitated by an experienced clinical psychologist with extensive clinical 
expertise in mindfulness-based therapeutic techniques and training. Part of the facilitator’s 
role was to observe and attend to any participants who displayed signs of emotional 
distress (e.g. leaving the room, becoming tearful or visibly upset, etc.), with a view to 
offering support or guiding participants through grounding techniques, commonly used 
during MBIs for such purposes; 
4. Participants were provided with contact details of researchers and facilitators, including 
possible routes to access support from other experienced clinicians within the service and 
who may have also been involved in participants’ usual care. 
 
2.10.2 Confidentiality 
Personal details for all participants were stored as per standard protocol and in accordance 
with local clinical governance guidelines on the NHS computer network (electronic patient 
record management system). Any data transferred from this location were anonymised 
accordingly with no details which would allow the individual to be identified. Any transfers 
carried out used an encrypted storage device. No data from the study was stored on any 
personal, University or laptop computers. However, both University and NHS computers 
were used during the data analysis and writing up of the present study. Both computer 
systems are password protected and use secure accounts. Any information accessed and 
used on these systems was encoded in anonymised formats. Raw data were stored in a 
locked filing cabinet at the research site for the duration of the study. 
 
2.10.3 Ethical review of the study 
Relevant guidance notes were consulted and advice was sought in respect of ethical review. 
In view of relevant research authorities’ considerations concerning minimal risk or harm to 
participants, the present study was deemed suitable for Proportionate Review. The study 
was reviewed by the Yorkshire and the Humber – South Yorkshire Local Research Ethics 
Committee (see Appendix 8 for the relevant letter of approval).  
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3. Results 
The results of the data analysis for are presented in the following order: 
(1) Descriptive statistics for the sample in question, including clinical profile and 
available socio-demographic information; 
(2) Descriptive statistics in respect of the research hypotheses concerning main  
outcome measures (both psychological and in terms of health-related quality of life, 
or HRQoL) at baseline for the whole sample (Groups 1, 2 and 3); 
(3) Distribution of mean scores for each of the primary and secondary outcome 
measures of interest at baseline assessment (i.e., pre-intervention, Groups 1, 2,3); 
(4) Distribution of mean scores for each of the primary and secondary outcome 
measures of interest post-intervention (i.e., Groups 1 and 2); 
(5) Statistical analysis in respect of the treatment completers and effects of the group  
on the outcome measures (i.e., Groups 1 and 2) relating to the main research 
hypotheses; 
(6) Intention-To-Treat (ITT) analysis taking into account participants who dropped out of 
the study (i.e., did not or were unable to complete measures post-intervention, or 
who did not attend the MBI group following agreement to participate) and for 
whom outcome data was unavailable. 
(7) Correlation analyses exploring the relationship between the outcome measures of 
interest pertaining to the intervention hypothesis; 
(8) A summary of key findings following analysis. 
3.1 Participants and Data Set 
3.1.1. Socio-demographic and clinical profile of participants 
A total of 22 individuals agreed to participate in the present study and were randomly 
assigned to one of three groups. Of these, 8 were allocated to the first group, 8 to the 
second, which ran immediately after the first group and completed, and 6 (of a possible 8) 
who had also agreed to take part in the study, attended a third group. This final group ran 
two weeks after the second group had completed treatment. The data and associated 
analyses are presented for the whole sample of 22 participants in the first instance. Tables 2 
and 3 outline study participants’ socio-demographic and clinical characteristics. 
61 
 
Table 2. Frequencies, percentages (and SDs) of socio-demographic variables for the 
total sample (N= 22) and by group. 
 
 Group 1 Group 2 Group 3 
Gender Male 3 (13.6%) 0 2 (25%) 1 (16.67%) 
 Female 19 (86.4%) 8 (100%) 6 (75%) 5 (83.33%) 
 Total 22 (100%) 8 (100%) 8 (100%) 6 (100%) 
Mean age  51.45 
(8.52) 
47.88 
(9.31) 
50.00 
(7.56) 
58.16  
(5.08) 
Ethnicity White 
British 
22 (100%) 8 (100%) 8 (100%) 6 (100%) 
 Total 22 (100%) 8 (100%) 8 (100%) 6 (100%) 
Marital 
status 
Single 7 (31.8%) 2 (25%) 3 (37.5%) 2 (33.33%) 
 Married 15 (68.2%) 6 (75%) 5 (62.5%) 4 (66.67%) 
 Total 22 (100%) 8 (100%) 8 (100%) 6 (100%) 
Employment 
status 
Employed 10 (45.5%) 5 (62.5%) 3 (37.5%) 2 (33.33%) 
 Unemployed 7 (31.8%) 2 (25%) 4 (50%) 1 (16.67%) 
 Retired 2 (9.1%) 0 1 (12.5%) 1 (16.67%) 
 Student 1 (4.5%) 1 (12.5%) 0 0 
 
 
Unavailable 2 (9.1%) 0 0 2 (33.33%) 
 Total 22 (100%) 8 (100%) 8 (100%) 6 (100%) 
 
As presented in Table 2, participants were predominantly female (86%), with the average 
age at baseline of 51.45 years (SD = 8.52).Group 1 consisted entirely of female participants, 
and had the lowest mean age (47.88 years, SD = 9.31). This is noteworthy in light of the 
tendency of certain neurological conditions (in particular, MS and PD) to be diagnosed 
between the ages of 20 and 50 years. In terms of ethnicity, the totality of participants 
described themselves as White British; this is representative of referrals received by the local 
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service. Also of note was participants’ occupational status, with just under a third (32%) 
currently unemployed. 
Table 3. Frequencies and percentages of neurological diagnosis by type (N = 22). 
 
Diagnosis Frequency Percent 
(%) 
  
Type 
ABI 4 18.2   
MS 12 54.5   
PD 4 18.2   
Other Neuro 2 9.1   
Total 22 100   
 
As presented in Table 3, it is perhaps worthwhile noting the proportions of participants in 
terms of their clinical diagnosis. Just over half of participants had a diagnosis of MS (54%), 
although the data did not distinguish between specific typology (e.g., whether benign, 
progressive or relapsing-remitting) or severity (e.g., time since diagnosis). This information is 
not routinely collected or held on the electronic patient record system as this is not a 
requirement of the service. Also, there were equal numbers of patients with a diagnosis of 
ABI and PD (n = 4 in each category, representing 36% of the total sample). As noted 
previously, the literature suggests that MS is a condition in which psychological issues are 
under-reported but particularly prominent (McGuigan and Hutchinson, 2006; Marrie et al., 
2008). 
3.2 Descriptive statistics: outcome measures at baseline assessment for the whole sample 
3.2.1 Primary outcome measures: measures of mindfulness 
Table 4 presents the results from the whole sample analysis for the two measures related to 
mindfulness. Boxplots of the distribution of scores relating to the FMI (general mindfulness) 
and MAAS (awareness and attention, dispositional mindfulness) are also shown (figs. 13 and 
14 respectively). Results show a fairly symmetrical distribution of scores, with little variation 
across groups despite the apparent heterogeneity in clinical profile and the large proportion 
of female participants. Exploration of these two variables revealed that assumptions for the 
use of parametric tests were met.  
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Table 4. Primary outcome measures (mindfulness: FMI; MAAS) at 
baseline; descriptive statistics. 
 
Group FMI (pre-) MAAS (pre-) 
1 
N 8 8 
Mean 37.25 3.20 
Median 37.50 3.20 
Minimum 31.00 2.47 
Maximum 46.00 4.07 
Std. Deviation 4.95 .51 
Skewness .37 .31 
Kurtosis .31 .01 
2 
N 8 8 
Mean 34.88 3.28 
Median 36.00 3.23 
Minimum 18.00 2.13 
Maximum 48.00 4.07 
Std. Deviation 9.00 .58 
Skewness -.67 -.88 
Kurtosis 1.10 1.70 
3 
N 6 6 
Mean 36.17 3.64 
Median 34.00 3.77 
Minimum 25.00 2.53 
Maximum 53.00 4.27 
Std. Deviation 9.58 .59 
Skewness 1.12 -1.61 
Kurtosis 1.80 3.48 
Total 
N 22 22 
Mean 36.09 3.35 
Median 36.50 3.33 
Minimum 18.00 2.13 
Maximum 53.00 4.27 
Std. Deviation 7.62 .56 
Skewness -.05 -.43 
Kurtosis 1.06 -.36 
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3.2.2 FMI 
General levels of mindfulness were measured using the Freiburg Mindfulness Inventory 
(FMI). A total score for the FMI was computed by adding scores for all 14 individual items. 
One item (item 13) was reversed, in accordance with the protocol as defined by the authors. 
The total score for the FMI ranges from 14 to 56. Higher scores denote higher levels of 
general mindfulness. The authors do not recommend using separate factor-scale scores.  
 
Fig. 13: Boxplots showing the distribution of FMI scores at baseline (N= 22). 
 
3.2.3 MAAS 
Dispositional levels of mindfulness as regards increased levels of attentional focus and 
awareness of present-moment experiences, both key concepts in the definition and 
operationalization of mindfulness, were measured using the 15–item Mindful Attention 
Awareness Scale (MAAS). A total score for the MAAS was computed by adding scores for all 
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individual items and dividing this by the number of items (i.e., 15) in order to derive an 
overall mean score. Higher scores reflect higher levels of dispositional mindfulness as 
defined by awareness and attention constructs. Mean scores range from 1 to 6 across the 15 
items.  
 
Fig. 14: Boxplots showing the distribution of MAAS scores (awareness and attention; 
dispositional mindfulness) at baseline (N = 22).Outliers are marked accordingly (ο;).2 
It is perhaps worthwhile commenting on the extreme case as represented by participant 21 
in Group 3 who reported a particularly low mean score on the MAAS at baseline assessment. 
3.2.4 Secondary outcome measures: measures of self-efficacy (MSES-R) 
Table 5 presents the results from the whole sample analysis for the outcome measure 
related to self-efficacy (MSES-R). Boxplots of the distribution of subscale scores relating to 
the MSES-R are also shown (fig. 15). Exploration of this variable revealed that assumptions 
for the use of parametric tests were met.  
                                                          
2
 Outliers are values at the lower or upper end that lie apart from the distribution. They are identified 
as cases that fall more than 1.5 box lengths (or 3 in extreme cases) from either hinge of the box. 
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Table 5. Secondary outcome measures (MSES-R) by subscale at baseline: descriptive statistics. 
Group    Emotional 
Regulation 
Equanimity Social  
Skills 
Distress  
Tolerance 
Taking 
Responsibility 
Interpersonal 
Effectiveness 
1 
N 8 8 8 8 8 8 
Mean 11.88 11.13 8.00 6.75 7.00 8.38 
Median 11.00 11.00 8.00 7.50 7.00 8.50 
Minimum 1.00 7.00 4.00 2.00 6.00 2.00 
Maximum 19.00 16.00 12.00 11.00 8.00 12.00 
Std. 
Deviation 
6.08 2.53 2.88 3.45 .76 3.25 
Skewness -.48 .52 -.29 -.22 .00 -1.05 
Kurtosis .03 2.26 -.66 -1.88 -.70 1.11 
2 
N 8 8 8 8 8 8 
Mean 8.38 9.50 8.13 6.50 5.00 6.25 
Median 8.50 9.50 8.00 7.00 4.00 6.00 
Minimum 2.00 6.00 4.00 2.00 3.00 3.00 
Maximum 15.00 13.00 12.00 11.00 11.00 9.00 
Std. 
Deviation 
5.26 2.67 2.53 3.02 2.56 2.05 
Skewness -.05 .00 -.12 -.19 2.31 .08 
Kurtosis -1.94 -.86 -.21 -.72 5.56 -.44 
3 
N 6 6 6 6 6 6 
Mean 10.83 9.00 7.17 6.17 4.50 9.00 
Median 11.50 7.50 7.50 6.00 4.00 8.50 
Minimum 4.00 6.00 3.00 3.00 2.00 8.00 
Maximum 18.00 13.00 11.00 10.00 8.00 11.00 
Std. 
Deviation 
4.96 3.16 2.99 2.99 2.17 1.26 
Skewness .03 .80 -.17 .16 .79 .89 
Kurtosis -.36 -1.87 -1.34 -2.04 .07 -.78 
Total 
N 22 22 22 22 22 22 
Mean 10.32 9.95 7.82 6.50 5.59 7.77 
Median 10.50 10.00 8.00 7.00 6.00 8.00 
Minimum 1.00 6.00 3.00 2.00 2.00 2.00 
Maximum 19.00 16.00 12.00 11.00 11.00 12.00 
Std. 
Deviation 
5.46 2.79 2.68 3.04 2.17 2.60 
Skewness -.11 .20 -.21 -.08 .52 -.50 
Kurtosis -.87 -.64 -.88 -1.43 .13 -.07 
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3.2.5 MSES-R 
Self-efficacy was measured using the 22-item Mindfulness-based Self-Efficacy Scale-Revised 
(MSES-R), a relatively new measure developed for both clinical and research purposes and 
adapted from the 35-item MSES, 16 of the questionnaire items are reversed. The MSES-R 
possesses a 6–factor structure which taps into defined components of self-efficacy. The 
range of scores for each subscale is 0 to 4. Total scores for each subscale vary since certain 
subscales contain more items than others. It is perhaps worthwhile mentioning that a global 
score of self-efficacy may also be computed (total scores can range from 0 to 88). 
 
Fig. 15: Boxplots showing the distribution of MSES-R subscale scores (self-efficacy) at 
baseline (N= 22). 
Of note is one outlier (participant 3) in group 1 for whom scores on the Equanimity subscale 
were relatively high in relation to other participants. 
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3.2.6 Secondary outcome measures: health-related quality of life (HRQOL) 
Table 6 presents the results from the whole sample analysis for the outcome measure 
related to health-related quality of life (Perceived Quality of Life Scale, PQoL) at baseline 
assessment. A boxplot of the distribution of scores relating to the PQoL is also shown (fig. 
16). Exploration of this variable revealed that assumptions for the use of parametric tests 
were met.  
 
Table 6. Secondary outcome measures (quality of life: PQoL) at baseline: descriptive statistics. 
 
Group N Mean Median Minimum Maximum Std. 
Deviation 
Skewness Kurtosis 
1 8 5.32 5.26 3.58 7.16 1.46 .05 -2.12 
2 8 5.01 4.68 3.32 7.68 1.26 1.36 3.34 
3 6 5.64 5.76 3.53 7.56 1.44 -.25 -.47 
Total 22 5.29 5.00 3.32 7.68 1.34 .33 -1.01 
 
 
3.2.7 PQoL 
Quality of life was measured using the Perceived Quality of Life Scale (PQoL) Scoring criteria 
involve computing the total of individual scores for 19 of the 20 items in the questionnaire 
and an overall score based on the mean or median of the 19 item scores. A population 
mean/median of 7.5 has been observed (N = 3359). Interpretation of the measure in cross-
sectional use is [<7.5 score is Dissatisfied] and [>7.5 score is Satisfied with perceived health-
related quality of life]. 
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Fig. 16: Boxplots showing the distribution of PQoL scores (health-related quality of life) at 
baseline (N = 22).The dotted line indicates a mean/median score of ≥7.5, interpreted as a cut-
off score (‘Satisfied’ with perceived quality of life). 
 
 
3.3 Descriptive statistics: outcome measures at post-intervention 
Since at the time of analysis data from only two of the three groups were available, the 
following section will present only data relating to Groups 1 and 2.Tables 7 and 8 outline the 
results of the data analysis in respect of the primary outcome measures pertaining to 
mindfulness at post-treatment assessment for these two groups for those participants who 
completed the intervention and/or were assessed. Boxplots showing the respective 
distributions of post-treatment scores are also included (figs. 17 and 18).  
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3.3.1 Primary outcome measures: measures of mindfulness (FMI) 
 
 
 
Fig. 17: Boxplots showing the distribution of FMI scores (general mindfulness) post-
intervention (n= 12). 
 
As can be seen from the above figure, two participants from the second group (10 and 13) 
appear to represent outliers. 
Table 7: Primary outcome measures (mindfulness; FMI) post-intervention: descriptive statistics 
(n = 12). 
 
Group N Mean Median Minimum Maximum Std. 
Deviation 
Skewness Kurtosis 
1 7 45.14 45.00 40.00 51.00 4.34 .12 -1.27 
2 5 39.80 40.00 33.00 47.00 5.07 .17 1.16 
Total 12 42.92 42.50 33.00 51.00 5.21 -.14 -.26 
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3.3.2 MAAS 
 
 
Table 8: Primary outcome measures (dispositional mindfulness; MAAS) post-intervention: 
descriptive statistics (n = 12). 
 
Group N Mean Median Minimum Maximum Std. 
Deviation 
Skewness Kurtosis 
1 7 3.96 4.13 3.20 5.13 .73 .40 -.92 
2 5 4.09 4.60 2.67 4.80 .89 -1.39 1.23 
Total 12 4.01 4.20 2.67 5.13 .76 -.35 -.98 
 
 
 
Fig. 18: Boxplots showing the distribution of MAAS scores (awareness and attention; 
dispositional mindfulness) post-intervention (n= 12). 
 
 
72 
 
3.3.3 Secondary outcome measures: measures of self-efficacy (MSES-R) 
Table 9 presents the results from the analysis for Groups 1 and 2 in respect of the MSES-R 
outcome measure at post-intervention by subscale. A boxplot of the distribution of subscale 
scores relating to the MSES-R is also shown (fig. 19). 
 
Table 9. Secondary outcome measures (self-efficacy; MSES-R) post-intervention: descriptive statistics. 
 
Group Emotional 
Regulation 
(post) 
Equanimity 
(post) 
Social Skills 
(post) 
Distress 
Tolerance 
(post) 
Taking 
Responsibility 
(post) 
Interpersonal 
Effectiveness 
(post) 
1 
N 7 7 7 7 7 7 
Mean 17.00 12.43 9.14 7.57 8.29 9.00 
Median 17.00 13.00 9.00 7.00 10.00 9.00 
Minimum 10.00 10.00 7.00 5.00 6.00 7.00 
Maximum 22.00 15.00 11.00 12.00 10.00 11.00 
Std. 
Deviation 
3.65 1.62 1.57 2.37 2.14 1.29 
Skewness -1.01 .01 .04 1.14 -.37 .00 
Kurtosis 2.59 .25 -1.68 1.18 -2.80 .31 
2 
N 5 5 5 5 5 5 
Mean 12.80 9.20 8.00 7.00 6.80 8.00 
Median 14.00 9.00 10.00 7.00 7.00 9.00 
Minimum 4.00 5.00 4.00 4.00 4.00 5.00 
Maximum 19.00 12.00 11.00 9.00 10.00 9.00 
Std. 
Deviation 
5.54 2.68 3.24 2.12 2.77 1.73 
Skewness -1.06 -1.00 -.59 -.52 -.01 -1.92 
Kurtosis 1.95 1.24 -2.90 -.96 -2.70 3.67 
Total 
N 12 12 12 12 12 12 
Mean 15.25 11.08 8.67 7.33 7.67 8.58 
Median 16.50 11.50 9.50 7.00 8.00 9.00 
Minimum 4.00 5.00 4.00 4.00 4.00 5.00 
Maximum 22.00 15.00 11.00 12.00 10.00 11.00 
Std. 
Deviation 
4.81 2.61 2.35 2.19 2.42 1.51 
Skewness -1.14 -.99 -.93 .61 -.36 -1.06 
Kurtosis 1.70 1.69 -.09 .50 -1.59 2.41 
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Fig. 19: Boxplots showing the distribution of MSES-R subscale scores (self-efficacy) post-
intervention (n= 12). 
 
It is perhaps worth commenting that in the case of one participant (9), scores on two of the 
MSES-R subscales represented outliers. 
 
3.3.4 Secondary outcome measures: quality of life measure (PQoL) 
 
Table 10 presents the results from the analysis for Groups 1 and 2 in respect of the PQoL 
(health-related quality of life) outcome measure at post-intervention. A boxplot of the 
distribution of scores relating to this measure is also shown (fig. 20). 
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Table 10. Secondary outcome measures (quality of life; PQOL) post-intervention: 
descriptive statistics (n = 12). 
 
Group N Mean Median Minimum Maximum Std. 
Deviation 
Skewness Kurtosis 
1 7 6.53 6.89 5.26 8.11 1.00 .25 -.85 
2 5 5.79 5.84 3.58 8.05 1.89 .01 -2.22 
Total 12 6.22 6.37 3.58 8.11 1.41 -.46 -.47 
 
 
 
Fig. 20: Boxplots showing the distribution of PQoL scores (health-related quality of life) post-
intervention (n= 12). 
 
As the above figure shows, it is evident that the distribution of mean scores was wider 
amongst participants in Group 2. 
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3.4 Testing the intervention hypotheses: between-group comparisons 
As previously outlined, the initial intervention hypothesis concerned the prediction that in 
comparison to a wait-list control group (i.e., group 3), as a result of receiving the 
mindfulness-based intervention, participants in the initial intervention group would show 
statistically significant improvements in measures associated with mindfulness as well as in 
relation to measures of self-efficacy and quality of life.  Given the study design adopted as 
described earlier (Fig. 11), it was decided to conduct appropriate analyses to test this 
hypothesis accordingly. Results are presented in Table 11. 
 
Table 11. Analysis of between-group comparisons (Group 1 post-intervention vs. Group 3 
baseline, n = 13). 
 
Primary outcome measures t Significance 
(p, 1-tailed) 
Mean differences 
(95% CI) 
Cohen’s d 
Mindfulness FMI 2.238 .024 8.98 (.15 & 17.8) 1.21 
MAAS .834 .21 0.31 (-.51 & 1.13) 0.47 
Secondary outcome measures     
Quality of 
life 
PQOL 1.303 .11 0.88 (-.61 & 2.38) 0.71 
Self-Efficacy MSES-R     
Subscales Taking 
Responsibility 
3.162 .005 3.79 (1.15 & 6.42) 1.76 
 Emotional 
Regulation 
2.581 .013 6.17 (.91 & 11.42) 1.42 
 Equanimity 2.521 .014 3.43 (.44 & 6.42) 1.36 
 Social Skills 1.525 .078 1.98 (-.88 & 4.83) 0.83 
 Distress 
Tolerance 
.945 .18 1.40 (-1.87 & 4.68) 0.52 
 Interpersonal 
Effectiveness 
.000 1.00 0.00(-1.57 & 1.57) 0 
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It can be seen from the table that across four of the measures of interest (or subscales 
thereof) statistically significant differences in mean scores were observed in the intervention 
group at post-intervention as compared to the control group at baseline assessment.  
Independent samples t-tests revealed significant differences in respect of the FMI, and three 
of the six MSES-R subscales (Taking Responsibility, Emotional Regulation and Equanimity 
respectively).  
It was also decided to conduct the same analysis using the corresponding non-parametric t-
tests (Mann-Whitney U test) in order to test the robustness of the t-tests due to the small 
sample sizes. The results from this analysis are displayed in Appendix 9 and would appear to 
lend further support the intervention hypothesis.  
 
3.4.1 Effect sizes 
Treatment effect sizes were calculated using Cohen’s d statistic (Cohen, 1988). It can be seen 
that compared to the control group (i.e., Group 3), the mean differences in scores for the 
intervention group evaluated (i.e., Group 1) at post-treatment assessment in respect of the 
FMI amounted to a very large effect size (d = 1.21). Very large effect sizes were also noted in 
respect of three of the six subscales of the MSES-R measure (Taking Responsibility, d = 1.76; 
Emotional Regulation, d = 1.42, and Equanimity, d = 1.36), with a further subscale (Social 
Skills) indicating a large effect size (d = 0.83). With regards to the PQoL measure, a large 
effect size was also noted (d = 0.71).  
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3.5 Testing the intervention hypotheses: within-group improvements over time 
As noted earlier, the intervention hypotheses concerned the prediction that as a result of 
attending the mindfulness-based intervention, participants would show improvements in 
outcome measures relating to mindfulness constructs (i.e., non-judgmental, present-
moment awareness, attentional focus) as defined by current literature, as well as 
improvements in measures relating to components of self-efficacy and perceived quality of 
life.  In order to ascertain changes in measures across time (i.e. pre-treatment and post-
treatment), analyses consisted of paired samples t-tests, provided assumptions for the use 
of parametric tests were met (i.e. homogeneity of variance, few/no extreme scores, normal 
distribution of data). As highlighted earlier, given the small sample size involved and 
evidence that these groups did not differ considerably in terms of their distributions, these 
analyses were conducted by amalgamating the first two groups of participants into one 
single group (n = 12) and to test for statistically significant improvements over time. 
 
3.5.1 Primary outcome measures: mindfulness (FMI, MAAS) 
A paired-samples t-test was conducted to compare mean scores on outcome measures of 
mindfulness (FMI, MAAS) at baseline and post-intervention. Results indicated that there was 
a significant difference in scores for the FMI measure (t (11) = -3.376, p =.006) with 
participants achieving an average increase post-intervention of 6 points (mean = 42.92, SD = 
5.21) in comparison to baseline assessment (mean = 36.50, SD = 7.60). The 95% confidence 
interval for the estimated population mean difference was between -10.6 and 2.23.  
Paired-samples t-tests conducted in respect of the MAAS also revealed a significant 
difference in scores from pre- and post-intervention (t (11) = -3.05, p = 0.011). Mean scores 
pre- (mean = 3.26, SD = .45) and post-intervention (mean = 4.01, SD = .76) differed by an 
average of over 0.7 points. The 95% confidence interval for the estimated population mean 
difference was between -1.3 and 0.21. 
3.5.2 Secondary outcome measures: quality of life (PQoL) 
Similarly, a statistical analysis using the paired-samples t-test was conducted to compare 
mean scores on the PQoL. Results indicated a significant difference in scores (t (11) = -3.349, 
p = 0.006). Participants achieved a mean difference of over 0.8 points at baseline (mean = 
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5.36, SD = 1.43) and post-treatment assessment (mean = 6.22, SD = 1.41). The 95% 
confidence interval for the estimated population mean difference was between -1.42 and -
.29. 
3.5.3 Secondary outcome measures: self-efficacy (MSES-R) 
As regards the MSES-R, the data were analysed for each of the six subscale scores using the 
paired-samples t-rest. Results indicated a significant difference in scores on the Emotional 
Regulation subscale (t (11) = -3.936, p = 0.002) and a significant difference on the Taking 
Responsibility subscale (t (11) = -2.821, p = 0.017). Within the Emotional Regulation 
subscale, participants achieved a mean difference in scores of 4.75 at baseline (mean = 10.5, 
SD = 6.11) and post-treatment assessment (mean = 15.25, SD = 4.81), whereas for the Taking 
Responsibility subscale, mean differences of 1.92 points were recorded between baseline 
(mean = 5.75, SD = 1.66) and post-treatment assessment (mean = 7.67, SD = 2.42).  
However, an analysis of the data for the other four MSES-R subscales – Equanimity, Distress 
Tolerance, Social Skills and Interpersonal Effectiveness – yielded contrasting results. Paired-
sample t-tests revealed no significant differences in mean scores for subscales relating to 
Equanimity (t (11) = .274, p = .789), Social Skills (t (11) = -.897, p = .389), Distress Tolerance (t 
(11) = .160, p = .876) and Interpersonal Effectiveness (t (11) = -.907, p = .384). It is perhaps 
worth noting that participants’ mean scores showed a decrease as regards the Equanimity 
(pre-treatment mean = 11.33, SD = 2.02; post-treatment mean = 11.08, SD = 2.61; decrease 
of 0.25 points) and Distress Tolerance subscales (pre-treatment mean = 7.50, SD = 3.03; 
post-treatment mean = 7.33, SD = 2.19; decrease of 0.17 points).  
3.5.4 Effect sizes and evaluation of the experimental hypotheses 
Treatment effect sizes were calculated using Cohen’s d statistic (Cohen, 1988). Effect sizes 
relating to primary and secondary outcome measures are presented in Table 12, along with 
an evaluation regarding the experimental hypotheses as defined previously. It can be seen 
that the mean differences in scores for completers at pre- and post-treatment assessment in 
respect of the mindfulness measures (FMI, MAAS) amounted to very large effect sizes (d = 
0.98 and d = 1.20 respectively). A moderate effect size was noted for the PQoL (d = 0.61) and 
large effect sizes were also noted for two of the six subscales on the MSES-R (Emotional 
Regulation, d = 0.86; Taking Responsibility, d = 0.92).  
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Table 12. Effect sizes, confidence intervals and evaluation of experimental hypotheses (n = 12). 
 
Primary outcome measures 
 
Cohen’s d 95% CI Decision 
Mindfulness 
 
FMI 
 
 
 
0.98 -10.6 and 2.23 Experimental hypothesis 
confirmed 
 MAAS 1.20 -1.3 and 0.21 Experimental hypothesis 
confirmed 
Secondary outcome measures  
Self-Efficacy 
 
MSES-R    
Subscales Taking 
Responsibility 
0.92 -3.41 and -4.22 Experimental hypothesis 
confirmed 
 Emotional 
Regulation 
0.86 -7.41 and -2.09 Experimental hypothesis 
confirmed 
 Interpersonal 
Effectiveness 
0.33 -2.57 and 1.07 Experimental hypothesis 
rejected 
 Social Skills  0.21 -1.73 and 0.73 Experimental hypothesis 
rejected 
 Equanimity  0.11 -1.76 and 2.26 Experimental hypothesis 
confirmed 
 Distress 
Tolerance  
0.06 -2.13 and 2.46 Experimental hypothesis 
rejected 
Quality of 
Life 
PQoL 0.61 -1.3 and 0.21 Experimental hypothesis 
confirmed 
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3.6 Intention-to-treat (ITT) analysis 
In order to test whether those participants who failed to complete or withdrew from the 
study (n=4) might have caused a bias towards an over-optimistic estimate of the effect sizes 
noted above, an Intention-to-treat (ITT) analysis was conducted. The four participants in 
question were therefore included in the analysis using their outcome measure scores at 
baseline assessment, for a total sample size n = 16. For ease of reference, mean differences 
are presented in Table 13 and are reported as negative values (i.e., baseline mean scores are 
subtracted from post-intervention mean scores as is standard practice) where there has 
been an increase in scores. Positive values denote mean scores which decreased for a 
specific outcome measure or subscale thereof. 
3.6.1 ITT analysis of primary outcome measures (mindfulness: FMI, MAAS) 
Paired-samples t-tests were conducted to compare mean scores on outcome measures of 
mindfulness (FMI, MAAS) at baseline and post-intervention. Results indicated that there was 
a significant difference in scores for the FMI measure (t (15) = -3.043, p =.008) with 
participants achieving a mean difference in scores of 4.81 in comparison to baseline 
assessment. The 95% confidence interval for the estimated population mean difference was 
between -8.18 and -1.44.  
Paired-samples t-tests conducted in respect of the MAAS also revealed a significant 
difference in scores pre- and post-intervention (t (15) = -2.803, p = 0.013). Mean scores pre- 
(mean = 3.24, SD = .53) and post-intervention (mean = 3.81, SD = .83) differed by 0.57 
points. The 95% confidence interval for the estimated population mean difference was 
between -1.00 and -0.14. 
3.6.2 ITT analysis of secondary outcome measures: PQoL 
Similarly, a statistical analysis using the paired-samples t-test was conducted to compare 
mean scores on the PQoL. Results indicated a significant difference in scores (t (15) = -3.022, 
p = 0.009). A mean difference of 0.65 points between baseline (mean = 5.16, SD = 1.33) and 
post-treatment assessment (mean = 5.81, SD = 1.46). The 95% confidence interval for the 
estimated population mean difference was between -1.09 and -.19. 
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Table 13. Intention-to-treat (ITT) analysis (n=16). 
Primary outcome measures Mean scores SD Mean 
score 
difference
1 
Significance 
(p) 
Mindfulness FMI pre 36.06 7.12 -4.81 0.008 
  post 40.88 6.41 
 MAAS pre 3.24 .52 -0.57 0.013 
  post 3.81 .83 
Secondary outcome 
measures 
 
Self-
Efficacy 
MSES-R      
Subscales Emotional 
Regulation 
pre 10.13 5.78 -3.56 0.004 
  post 13.69 5.51 
 Equanimity pre 10.31 2.65 0.18 .786 
  post 10.13 2.94 
 Social Skills pre 8.06 2.62 -0.38 .383 
  post 8.44 2.53 
 Distress 
Tolerance 
pre 6.63 3.14 0.13 .874 
  post 6.50 2.53 
 Taking 
Responsibility 
pre 6.00 2.10 -1.44 0.019 
  post 7.44 2.58 
 Interpersonal 
Effectiveness 
pre 7.31 2.85 -0.56 .378 
  post 7.87 2.13 
Quality of 
Life 
PQoL pre 5.16 1.33 -0.64 0.009 
  post 5.81 1.46 
1 
Negative values denote improvements in mean scores. 
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3.6.3 ITT analysis of secondary outcome measures: MSES-R 
As regards the MSES-R, the data were analysed for each of the six subscale scores using the 
paired-samples t-rest. Results indicated a significant difference in scores on the Emotional 
Regulation subscale (t (15) = -3.423, p = 0.004) and a significant difference on the Taking 
Responsibility subscale (t (15) = -2.626, p = 0.019).Within the Emotional Regulation subscale, 
taking into account non-completers, participants achieved a mean difference in scores of 
3.56 between baseline (mean = 10.13, SD = 5.79) and post-treatment assessment (mean = 
13.69, SD = 5.51), whereas for the Taking Responsibility subscale, mean differences of 1.44 
points were recorded between baseline (mean = 6.00, SD = 2.10) and post-treatment 
assessment (mean = 7.44, SD = 2.58). 
3.6.4 Effect sizes and evaluation of the experimental hypotheses following ITT analysis 
Treatment effect sizes were calculated using Cohen’s d statistic (Cohen, 1988). Effect sizes 
relating to primary and secondary outcome measures are presented in Table 14, along with 
an evaluation regarding the experimental hypotheses as defined previously. It can be seen 
that the mean differences in scores for completers at pre- and post-treatment assessment in 
respect of the mindfulness measures (FMI, MAAS) amounted to large effect sizes (d = 0.71 
and d = 0.82 respectively). A medium effect size was noted for the PQoL (d = 0.47) with 
medium effect sizes also noted for two of the six subscales on the MSES-R (Emotional 
Regulation, d = 0.63; Taking Responsibility, d = 0.61). Finally, a small effect size was noted for 
the subscale relating to Interpersonal Effectiveness (d = 0.22). 
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Table 14. Effect sizes, confidence intervals and evaluation of experimental hypotheses following 
Intention-to-treat (ITT) analysis (n= 16). 
 
Primary outcome measures 
 
Cohen’s d 95% CI Decision 
Mindfulness 
 
FMI 
 
 
 
0.71 -8.18 and -1.44 Experimental hypothesis 
confirmed 
 MAAS 0.82 -1.00 and -0.14 Experimental hypothesis 
confirmed 
Secondary outcome measures  
Self-Efficacy 
 
MSES-R    
Subscales Emotional 
Regulation 
0.63 -5.78 and -1.34 Experimental hypothesis 
confirmed 
 Taking 
Responsibility 
0.61 -2.60 and -0.27 Experimental hypothesis 
confirmed 
 Interpersonal 
Effectiveness 
0.22 -1.88 and 0.76 Experimental hypothesis 
rejected 
 Social Skills 0.15 -1.26 and 0.51 Experimental hypothesis 
rejected 
 Equanimity 0.07 -1.26 and -1.63 Experimental hypothesis 
rejected 
 Distress 
Tolerance 
0.04 -1.52 and 1.77 Experimental hypothesis 
rejected 
Quality of 
Life 
PQoL 0.47 -1.09 and 0.19 Experimental hypothesis 
confirmed 
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3.7 Correlational analyses 
Given that the results of the analyses appeared to confirm the intervention hypothesis, it 
was considered useful to establish to what extent the outcome measures used in the current 
study potentially tapped into similar, or indeed different, aspects of the psychological 
variables of interest. To this end, it was decided to undertake correlational analyses to 
explore these relationships. 
3.7.1 Primary outcome measures: mindfulness (FMI and MAAS) 
Spearman’s rho indicated that the FMI and MAAS measures of mindfulness were not 
correlated with each other in respect of the participants’ mean scores. This held for baseline 
assessment (rs = .09, n = 22, p = .34) as well as post-intervention for treatment completers (rs 
= .07, n = 12, p = .41).  Associated scatterplots for the correlational analyses were 
constructed and are also shown in figs. 21 and 22 respectively. This would appear to suggest 
that the FMI and MAAS tap into quite distinct components of mindfulness, with the former 
appearing to be a more ‘general’ measure of mindfulness, whilst the latter appears to 
capture aspects of mindfulness related to attentional focus and awareness of mental, 
physical and sensory experience.    
3.7.2 Secondary outcome measures: self-efficacy (MSES-R) 
Similarly to the primary outcome measures, it was considered useful to examine to what 
extent the two subscales of the MSES-R hung together in terms of their purported 
operational constructs of self-efficacy. Spearman’s rho indicated that there was a moderate 
positive correlation between the Emotional Regulation and Taking Responsibility subscales 
of the MSES-R pre-intervention (rs = .52, n = 22, p = .007) which was statistically significant. 
Post-intervention, however, Spearman’s rho indicated a weaker correlation between the 
subscales (rs = .33, n = 12, p = .15) which was not significant.   
3.7.3 Secondary outcome measures: quality of life (MSES-R and PQOL) 
An analysis of the relationship between the MSES-R self-efficacy subscales of interest and 
the quality of life measure (PQoL) was also conducted. Spearman’s rho indicated a modest 
correlation between the Emotional Regulation subscale and the PQoL at baseline (rs = .42, n 
= 22, p =.026) which was statistically significant. However, post-intervention, this correlation 
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was weaker (rs = .28, n = 12, p =.19) and was not statistically significant. As regards the 
Taking Responsibility subscale, Spearman’s rho indicated no correlation between the 
variables either pre-intervention (rs = .02, n = 22, p = .47) or post-intervention (rs = .12, n = 
12, p = .36).  
 
Fig. 21: Scatterplot showing correlational analysis of primary outcome measures (FMI vs. 
MAAS) at baseline assessment. Intersecting lines for the x- and y-axes indicate mean scores 
for each measure. 
 
These results would appear to suggest that there is a relationship between the Emotional 
Regulation subscale of the MSES-R and the PQoL, and therefore it could be tentatively 
surmised that aspects of self-efficacy which relate to an ability to recognise, understand and 
manage difficult or uncomfortable emotional experiences appropriately may be correlated 
with participants’ perceived quality of life.  
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Fig. 22: Scatterplot showing correlational analysis of primary outcome measures (FMI vs. 
MAAS) post-intervention. Intersecting lines for the x- and y-axes indicate mean scores for 
each measure. 
 
3.8 Analysis of gain scores 
In light of the intervention hypotheses, which predicted that an increase in mindfulness skills 
(as defined and measured by the FMI and MAAS) would bring about improvements in 
participants’ self-reported self-efficacy and perceived quality of life (as defined and 
measured by the MSES-R and PQoL respectively), it was important to explore the inter-
individual differences in gain scores resulting from the MBI under evaluation in order to 
understand more fully the potential mechanisms of change involved in these improvements. 
To this end, it was decided to further explore that to what extent the improvement in the 
latter scores could be reliably attributed to gains in the former. Additional correlational 
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analyses were conducted. In order to explore the relationship between mean differences 
and gain scores on the mindfulness measures and those variables associated with self-
efficacy and quality of life, additional correlational analyses were conducted between these 
scores for treatment completers (n = 12). Table 15 presents the main descriptive statistics 
for the gain scores in respect of the variables of interest. 
 
Table 15. Gain scores for selected variables of interest: descriptive statistics (n = 12). 
 
    Mean Median Minimum Maximum Std. 
Deviation 
Skewness Kurtosis 
Measure 
FMI 6.42 6.50 -6.00 15.00 6.58 -.32 -.68 
 
MAAS .76 .83 -.60 2.20 .86 .04 -.89 
 
MSES-R: ER
1 
4.75 6.00 -2.00 9.00 4.18 -.70 -1.03 
MSES-R: TR
2 
1.92 2.00 -1.00 6.00 2.35 .32 -1.08 
PQoL .86 .79 -.32 2.63 .88 .56 -.09 
1 
Emotional Regulation subscale. 
2
 Taking Responsibility subscale.
  
 
It can be seen from the table that the FMI gain scores appeared to be more widely 
distributed than the other measures. Of particular note are the relatively small distribution 
patterns of the MAAS and PQoL gain scores. 
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Fig. 23: Boxplots showing distribution of gain scores across primary and secondary outcome 
measures of interest (n = 12). 
 
As can be seen from the above set of boxplots, the respective distributions of the gain scores 
for the variables of interest appear relatively normal. Median gain scores were higher for the 
FMI (6.5 points and the Emotional Regulation subscale of the MSES-R (6.00 points) 
3.8.1 Gain score analysis for FMI and MAAS 
In respect of the two primary outcome measures of mindfulness, Spearman’s rho indicated 
that there was a weak-to-moderate positive relationship associated with gain scores on the 
FMI and the MAAS (rs = -.33, n = 12, p = .14) which did not approach statistical significance.   
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3.8.2 Gain score analysis for FMI and MSES-R subscales of interest 
Scatterplots relating to the gain scores in respect of the FMI mindfulness measure and the 
MSES-R subscales representing Emotional Regulation and Taking Responsibility are 
presented in figs. 24 and 25. It is perhaps worth noting that one participant did not appear 
to have shown improvements across either measure. 
 
Fig. 24: Scatterplot showing correlational analysis of gain scores between the FMI and 
Emotional Regulation subscale of the MSES-R measure. 
 
Spearman’s rho indicated that there was a weak positive relationship associated with gain 
scores in respect of the FMI and the Emotional Regulation subscale of the MSES-R (rs = .34, n 
= 12, p = .14) and a similarly weak  positive relationship associated with gain scores on the 
Taking Responsibility subscale (rs = .30, n = 12, p = .17). 
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Fig. 25: Scatterplot showing correlational analysis of gain scores between the FMI and Taking 
Responsibility subscale of the MSES-R measure. 
 
3.8.3 Gain score analysis for MAAS and MSES-R subscales of interest 
Scatterplots relating to the gain scores in respect of the MAAS mindfulness measure and the 
MSES-R subscales representing Emotional Regulation and Taking Responsibility are 
presented in figs. 26 and 27 respectively. Again, it is worth noting that in the case of one 
participant, scores did not improve across either variable. 
Spearman’s rho indicated that there was a moderately positive relationship associated with 
gain scores in respect of the MAAS and the Emotional Regulation subscale of the MSES-R (rs 
= .49, n = 12, p = .049) which was statistically significant.  A moderately positive relationship 
associated with gain scores on the Taking Responsibility subscale was also noted (rs = .48, n = 
12, p = .058) which approached statistical significance. 
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Fig. 26: Scatterplot showing correlational analysis of gain scores between the MAAS and 
Emotional Regulation subscale of the MSES-R measure. 
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Fig. 27: Scatterplot showing correlational analysis of gain scores between the MAAS and 
Taking Responsibility subscale of the MSES-R measure. 
 
3.8.4 Gain score analysis for primary outcome measures and PQoL 
 
Scatterplots relating to the gain scores in respect of each of the primary outcome measures 
and the PQoL (quality of life) are presented in figs. 28 and 29 respectively. Again, it is worth 
noting that in the case of one participant, scores did not improve across either variable in 
respect of the MAAS. 
 
Spearman’s rho indicated that there was a weak positive relationship associated with gain 
scores in respect of the FMI and the PQoL measure (rs = .24, n = 12, p = .22).  As regards the 
MAAS, a moderately strong positive relationship associated with gain scores on the PQoL 
was noted (rs = .59, n = 12, p = .021) which was statistically significant. 
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Fig. 28: Scatterplot showing correlational analysis of gain scores between the FMI and 
Perceived Quality of Life (PQoL) measure. 
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Fig. 29: Scatterplot showing correlational analysis of gain scores between the MAAS and 
Perceived Quality of Life (PQoL) measure. 
 
 
3.9 Brief synopsis of results  
 Compared to a wait-list control (WLC) group, significant differences in mean scores 
for the intervention group across the FMI and 3 of the 6 subscales for the MSES-R 
would appear to suggest the effectiveness of the MBI in question, with large effect 
sizes noted in respect of these 
 Significant differences in mean scores pre- to post-intervention would appear to 
suggest that MBI in question is clinically effective in improving individuals’ trait and 
dispositional mindfulness skills (for both primary outcome measures – FMI and 
MAAS) 
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 Significant differences in mean scores pre- to post-intervention as regards 2 of the 6 
subscales within the self-efficacy secondary outcome measure (MSES-R; constructs 
relating to Emotional Regulation and Taking Responsibility) appear to suggest that 
the MBI in question was effective in bringing about clinical improvements in these 
areas 
 Significant differences in mean scores pre- to post-intervention in respect of the 
secondary outcome measure related to health-related quality of life (PQoL) appear 
to suggest that the MBI in question was effective in bringing about clinical 
improvements in participants’ perceived quality of life 
 Large treatment effect sizes were noted in respect of the FMI and MAAS (d = 0.98 
and d = 1.20 respectively) 
 Similarly, large treatment effect sizes were noted in respect of the Emotional 
Regulation and Taking Responsibility subscales of the MSES-R (d = 0.86 and d = 0.92 
respectively) 
 A medium treatment effect size was noted in respect of the PQoL (d = 0.61) 
 These findings held when treatment non-completers were taken into account and 
results were analysed via an Intention-to-treat (ITT) analysis (n = 16) 
 Further correlational analyses revealed that the primary outcome measures of 
interest appeared to tap into very different aspects or constructs associated with 
mindfulness (i.e., there appeared to be very little overlap in terms of the 
components of mindfulness each measure purported to reflect) 
 An analysis of gain scores on the FMI and MAAS in respect of the secondary 
outcome measures (for which a significant difference was noted) revealed a 
moderately strong relationship between the MAAS and the 2 subscales of the MSES-
R as well as the PQoL which was statistically significant 
 This would appear to suggest that improvements in mindfulness skills associated 
with awareness and attention (as measured by the MAAS) increased participants’ 
ability to regulate their emotions and take responsibility (as measured by the MSES-
R) and brought about an increase in their perceived quality of life (as measured by 
the PQoL). 
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4. Discussion  
 
4.1 Outline of discussion section 
The present study sought to evaluate the effectiveness of a recently instituted, modified, 
non-manualized, short-form Mindfulness-based intervention (MBI) with a mixed clinical 
population presenting with ABI or chronic neurological conditions (MS, PD). The intervention 
was delivered in a group format in a community neuro-rehabilitation setting. More 
specifically, the study was interested in ascertaining whether the MBI in question would 
bring about reliable clinical improvement in psychometric measures associated with 
increased mindfulness skills (FMI, MAAS) and whether as a result of these improvements, 
these were predictive of improvements in measures relating to self-efficacy (as measured by 
the MSES-R) and health-related quality of life (as measured by the PQoL).  
This chapter is divided into three main areas. Firstly, the essential findings in relation to the 
experimental hypotheses, along with additional associated analyses, are summarized and 
interpreted. These are discussed in comparison to the published research literature.  
Findings are discussed in the context of possible implications of the present study as regards 
its clinical relevance. Secondly, study limitations and methodological issues are discussed, 
with an emphasis on continuing debates concerning the definitions, operationalization and 
psychometric properties of mindfulness. Lastly, in view of these considerations, potential 
future directions for research are discussed and preliminary conclusions from the study are 
drawn. 
 
4.2 Overview of results: main findings 
4.2.1 Participants: clinical and socio-demographic characteristics of the sample 
It is evident from the participant dataset for the whole sample (n = 22) that the vast majority 
of participants in this study were women (86.4%), with over half of the sample having a 
diagnosis of MS (54.5%), and equal numbers of participants with a diagnosis of PD or an ABI 
(18.2% in each group) Overall, neurological conditions represented over 80% of the total 
sample. This is not particularly unusual in itself, given the higher prevalence amongst women 
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in the general population for certain neurological conditions (estimates concerning the 
female-male ratio for MS in the UK are approximately 2:1). This may also appear to reflect a 
commonly held belief regarding the purported tendency for women to report psychological 
difficulties or indeed present to services more readily than men.  
In socio-demographic terms, the total sample could be considered relatively homogeneous, 
if ethnicity (all participants identified themselves as White British), age distribution, marital 
status and occupational functioning are taken into account (although there did appear to be 
a higher percentage of the sample who at the time of assessment were not in employment). 
However, it would have been perhaps useful to explore the relationships between these 
variables and outcome data in order to understand whether particular factors were in some 
way predictive of clinical improvements or otherwise. 
 
4.2.2 Evaluation of research hypotheses: comparison to controls 
Hypothesis (1): The adapted MBI under investigation will lead to increases in mindfulness, 
self-efficacy and quality of life, and so the intervention group will report higher means on 
relevant outcomes measures at the end of the MBI training in comparison to a wait-list 
control group. 
Mean scores across all outcome measures for the initial intervention group at post-
intervention were compared against corresponding baseline scores for the control group 
(group 3). Results revealed statistically significant improvements in the former in respect of 
the FMI mindfulness measure, as well as three of the six subscales of the MSES-R self-
efficacy measure (Emotional Regulation, Equanimity and Taking Responsibility respectively). 
A calculation of effect sizes revealed large or very large effects for the above variables as 
well as for health-related quality of life (ranging from Cohen’s d = 0.71 to 1.76). The research 
hypothesis was therefore confirmed. 
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4.2.3 Primary outcome measures: improvements in measures associated with mindfulness 
Hypothesis (2): The MBI training will lead to significant improvements in mindfulness skills 
which, in turn, will produce beneficial effects on self-efficacy and quality of life. It is therefore 
predicted that the means on relevant outcome measures will be higher at the end of the MBI 
training relative to the means at baseline assessment. 
An initial analysis of data available for participants from the first two groups (for which post-
intervention scores were available; n = 12) found that participants exhibited statistically 
significant improvements in mean score differences relating to the primary outcome 
measures associated with mindfulness (FMI and MAAS) at post-intervention compared to 
baseline assessment. Treatment effect sizes were computed accordingly and results 
indicated large effect sizes for each measure. This clearly appears to provide evidence that 
the intervention was effective and produced considerable benefits in terms of mindfulness 
skills training and acquisition. The research hypothesis was therefore confirmed. 
An Intention-to-treat (ITT) analysis was conducted to take into account participants who 
dropped out of the study, declined or did not complete assessments at post-intervention (n 
= 4). For these cases, the data were analysed using participants’ baseline scores. Differences 
in mean scores were also found to be statistically significant for both the FMI and MAAS. 
Treatment effect sizes, whilst understandably smaller than the preliminary analysis, 
remained nonetheless large. This would further appear to support and confirm the research 
hypothesis. The effect sizes noted would seem consistent with, but suggest larger treatment 
effects, to similar studies in the current literature (see Azulay et al., 2013 for a similar recent 
study). 
 
4.2.4 Secondary outcome measures: improvements in measures associated with self-efficacy 
and health-related quality of life 
It was hypothesised that changes in respect of the secondary outcome measures employed 
in the study, which were associated with self-efficacy (MSES-R) and health-related quality of 
life (PQoL), would be contingent on changes in mindfulness (i.e. acquisition of mindfulness 
skills as measured by the FMI and MAAS). In line with this, analysis of the data revealed that 
mean scores pre- to post-intervention improved in two of the self-efficacy subscales 
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(concerned with Emotional Regulation [ER] and Taking Responsibility [TR] respectively) at a 
statistically significant level. Mean scores improved in a further two subscales (namely Social 
Skills and Interpersonal Effectiveness), however were not found to be statistically significant. 
In contrast, however, mean scores decreased in subscales associated with variables 
pertaining to distress tolerance and equanimity. A calculation of effect sizes indicated large 
effect sizes in respect of the ER and TR subscales of the MSES-R.  
With respect to the quality of life measure (PQoL), an analysis of the data indicated 
statistically significant differences in mean scores post-intervention in the expected direction 
as proposed by the intervention hypothesis. A moderate effect size was observed.  
As per the analysis undertaken with the primary outcome measures, an ITT analysis of the 
secondary outcome measures (n = 16) revealed statistically significant improvements in 
scores from baseline to post-intervention in regards to the ER and TR subscales of the MSES-
R self-efficacy measure. Similarly, the ITT analysis indicated statistically significant 
improvements from pre- to post-intervention for the PQoL measure.  
Moderate to large effect sizes were noted for the ER and TR self-efficacy variables, with a 
moderate effect size observed for the PQoL measure. Again, these were consistent with the 
recent literature (Bédard et al., 2003; 2005; Grossman et al., 2004; Azulay et al., 2013) and 
the findings provide further evidence for the effectiveness of the MBI in question in terms of 
improving patients’ self-reported levels of self-efficacy in at least two distinct domains as 
well as their perceived quality of life.  
 
4.3 Overview of additional analyses 
4.3.1 Correlational analysis of primary outcome measures 
In order to determine to what extent the outcome measures outlined above tapped into 
similar or distinct constructs, it was decided to conduct non-parametric correlational 
analyses (Spearman’s r) in order to further examine the relationship between the two 
primary outcome measures as well as the secondary outcome measures. In terms of the FMI 
and MAAS, both at baseline and post-intervention, the analysis indicated no correlation 
between the measures. This appeared to suggest that the FMI and MAAS captured quite 
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different aspects of mindfulness as conceptualised by current research. Indeed, in 
psychometric terms, the FMI is considered a global measure of mindfulness, whilst the 
MAAS (as the name would suggest) emphasises components associated with attentional 
focus and awareness of moment-to-moment experience.  
 
4.3.2 Correlational analyses of secondary outcome measures 
Correlational analyses in respect of the ER and TR subscales of the MSES-R measure 
indicated a moderate positive association between these variables at baseline which was 
statistically significant. However, this association, whilst still positively correlated, was 
somewhat weaker at post-intervention and did not approach significance. An analysis of the 
potential relationship between the aforementioned MSES-R subscales and the PQoL 
measure revealed a modest association between the ER subscale and PQoL at baseline 
which was statistically significant, but which did not hold at post-intervention. The TR 
subscale did not appear to be correlated with the PQoL either pre- or post-intervention. 
 
4.3.3 Gain score analysis 
Given the initial findings providing preliminary evidence for the effectiveness of the MBI 
under evaluation, it was deemed useful to further analyse the individual gain scores in order 
to explore to what extent the size of improvements in self-efficacy and quality of life might 
be related to, and explained by, corresponding sizes of improvement in mindfulness skills as 
observed. According to this analysis, a median improvement of 6 points or over was 
observed on the FMI and ER measures, with smaller improvements noted for the MAAS, TR 
and PQoL.  
An initial gain score analysis of the FMI and MAAS revealed a modest correlation between 
the two measures. This is an interesting finding when one considers that the preliminary 
correlational analysis conducted in respect of these two measures did not suggest an 
association between them. Further analyses in respect of gain scores on the FMI and MAAS 
as compared to the MSES-R and PQoL revealed a somewhat mixed picture, but three 
findings are noteworthy. It appears that the MAAS gain scores are positively correlated with 
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both the ER and TR subscales of the MSES-R, and that these relationships approach, or are 
statistically significant. A stronger relationship was noted in respect of MAAS and PQoL gain 
scores.  
 
4.4 Interpretation of findings 
In line with the recent literature, the results from this study would appear to broadly confirm 
the effectiveness of the MBI in question for the population evaluated in the current study. 
Despite some limitations, it could be surmised that the present research has contributed to 
the literature and evidence base which suggests that an adapted MBI provides demonstrable 
clinical benefits to this population with regards to measures of self-efficacy (i.e., participants’ 
beliefs about being able to respond to and cope with the challenges of their diagnosis or 
condition and associated difficulties), specifically those concerned with regulating emotions 
and taking responsibility for the reactions and responses to one’s difficulties.  
The findings also appear to point to participants’ registering a higher sense of satisfaction 
and consequent improved quality of life as a result of the intervention. These findings 
appear to support other studies which have examined this construct with similar populations 
(e.g., Bédard et al., 2003, 2005; Cicerone and Azulay, 2007), albeit employing different 
psychometrics to evaluate this.  For example, Flugel Colle et al. (2010) reported a statistically 
significant improvement in overall quality of life and across specific domains of well-being 
(e.g., physical, mental, emotional and social activity) as a result of individuals with chronic 
conditions attending an MBSR programme. 
There are a number of possible interpretations which may be drawn from the findings. The 
large treatment effect sizes which were observed in terms of the primary outcome measures 
(mindfulness) would appear to suggest that participants’ training in mindfulness skills 
increased significantly as a result of the MBI. Perhaps more importantly, these increases 
appeared to directly influence and engender, to an extent, clinical benefits in terms of 
increased emotional regulation and taking responsibility within the context of self-efficacy. 
Additionally, clinical benefits were noted in terms of improved self-reported quality of life.  
In speculating on what psychological processes or mechanisms might have brought about 
these benefits, it is perhaps useful to bear in mind the various theories and 
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conceptualisations concerning mindfulness’ purported properties. Given that participants 
were all sufferers of chronic health conditions, with uncertain prognoses and a sense of lack 
of control over this, the opportunity to acquire new skills and mastery in a set of practical 
techniques to manage the psychological and emotional impact of their conditions may have 
brought about a perception of increased self-efficacy. This in turn may have had a further 
effect on their perceptions of how satisfied they may have felt in certain aspects of their 
lives. This appears to be reminiscent of the transactional theory and model of stress 
appraisal by Lazarus and Folkman (1984) which postulates that an individual’s resources and 
perceived ability to cope are the drivers and mediators in the appraisal and subsequent 
response to stressors. A possible explanation for the present study’s findings may be rooted 
in this ability having been developed or enhanced to an extent via the MBI. 
From a psychological perspective,  and perhaps connected to the idea of re-appraisal, within 
the intervention itself and the various exercises contained therein, the emphasis on 
developing an awareness of mental and sensory experiences in a manner which fostered a 
more detached perspective on these experiences so as to bring about what in the literature 
Carmody et al. (2009) and Shapiro et al. (2006), amongst others, have denoted as “re-
perceiving” (i.e., a re-appraisal of distressing events) may have also contributed to an 
increased sense of self-efficacy in terms of an improved capacity for self-regulation and 
emotional control. This would also appear to be linked to the concept of mental proliferation 
as proposed by the BPM (Grabovac et al., 2011) and highlighted earlier, in which the practice 
of attention regulation appears to bring about an attenuation and interruption of this 
maladaptive process. 
One cannot dismiss entirely the possible role of expectancy effects when considering the 
large treatment/training effect sizes observed in the first group in comparison to controls. 
There may have been a degree of enthusiasm among participants in terms of their receiving 
the intervention. Conversely, there is a possibility that those assigned to the control group 
may have experienced a sense of disappointment which may well have mitigated against 
otherwise spontaneous improvements over time.  
It is also difficult to isolate the precise mechanisms of action or specific techniques that may 
account for the improvements seen. Other aspects of the group besides the mindfulness 
practices, such as the opportunity to take an active role in their own self-management, 
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social support, the normalisation of their difficulties with others, or cognitive techniques, 
may also have exerted beneficial effects. It is worth bearing in mind that the strong effect 
sizes noted in the study emerged despite variations in participants’ attendance of individual 
sessions. 
 
However, these interpretations remain speculative to an extent, and some caution must be 
exercised in terms of generalising findings in view of the study’s limitations, methodological 
considerations and the specific format of the intervention under evaluation. These 
considerations merit further discussion and are set out later in this section.  
 
4.5 Clinical relevance and implications 
It is clear that psychological difficulties are common among populations adjusting to life 
post-ABI or indeed diagnosis of a long-term or progressive neurological condition, and that 
these may be overlooked.  The quantitative literature continues to support and bear this out 
increasingly, and recent qualitative research in the area of ABI is also indicating this (e.g., 
Bamford, 2008). Thus the evidence base is growing exponentially in this area. Research with 
other populations is already influencing service and policy development, with some MBIs 
(e.g. MBCT) already included in clinical guidelines for the treatment of specific mental health 
or psychiatric disorders such as recurrent depression (NICE, 2009). 
This would point to the increasing acceptability of MBIs across many settings and would 
appear to highlight their potential viability and benefit amongst populations with a variety of 
chronic health conditions. The promising results from the present study would appear to 
further support this view and it is hoped that in some way this might also contribute to the 
evidence base as regards future policy and guideline development in the neurological and 
neuropsychological arena. There is also an opportunity for the clinical psychology profession 
in developing a prominent role in terms of spearheading and developing MBI approaches 
with neurological populations and within neuropsychological services, influencing service 
organisation, development and delivery for ABI and neurological patients and informing 
future policy and clinical guidance. As mentioned earlier, the BPS has already published 
guidelines on this.  
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In practical and logistical terms, since MBIs are considered part of the “Third Wave” of 
cognitive-behavioural interventions, they may lend themselves more readily to 
manualization as well as to further adaptations or refinements, with interventions being 
specifically tailored to suit the needs of diverse populations, as was the case in the present 
study. This flexibility has potential benefits across a variety of service areas, not least in 
terms of service delivery (MBIs are equally applicable to group and individual therapeutic 
formats). The MBI evaluated in the present study did not appear to be harmful to 
participants (as further evidenced by anecdotal and written feedback via the evaluation 
forms) nor did the exercises and practices contained therein appear to be overly taxing or 
intensive for patients, with many providing informal feedback on the relative ease with 
which they were able to maintain the practices introduced between sessions. Integrating 
MBI approaches into long-term neuro-rehabilitation packages, self-management and care 
pathways as part of a more holistic approach to healthcare with this patient population (and 
in accordance with national clinical guidelines which increasingly emphasise and advocate 
for these approaches) would therefore also seem to be a relatively straightforward and safe 
practice. 
In addition, there are potential financial implications to the adoption of MBIs with regards to 
neurological services. The need to find innovative and sustainable models of service for a 
population with long-term needs would appear vital in the current climate.  With ever larger 
volumes of referrals, as well as improved prognoses and increased life expectancy within this 
population, group-based interventions such as MBIs, and in particular, briefer ones, as 
evaluated in the present study, may well be a cost-effective option in the long term (Segal, 
Williams and Teasdale, 2002). Furthermore, group-based interventions may provide 
psychosocial benefits in assisting patients to foster links and support amongst themselves 
(one participant discussed with others setting up a regular series of informal meetings with 
other members of the group in order to maintain mindfulness practice, share experiences 
and support each other). There may be a further role for clinical psychologists in facilitating 
this, and possibly in training professionals from other specialist disciplines to facilitate and 
deliver MBI programmes. Lastly, this study would suggest that MBIs may be offered as a 
potential adjunct to other types of therapeutic or rehabilitative interventions as well as 
concurrently with other conventional treatments. 
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4.6 Study limitations and suggested improvements or modifications 
It is useful to consider both design limitations and potential methodological shortcomings in 
light of this study’s findings, since in the first instance they may assist in the interpretation of 
findings in respect of validity and reliability. Secondly, they may prove useful indicators for 
future directions of research. 
 
4.6.1 Statistical power of the study 
Inadequate statistical power (mainly due to small sample sizes) is a major limitation of many 
MBI studies (Baer, 2003; Chiesa and Serretti, 2011). This could entail a threat to the external 
validity and therefore a lack of generalizability of findings. One limitation of this study was 
the small sample size, both in terms of the whole sample (i.e., the number of participants 
assessed at baseline, n = 22) and the sample for which the statistical analyses were 
conducted (within-groups comparison, n = 12; control group comparison n = 13; ITT analysis, 
n = 16). As mentioned previously, as per the original study design, an initial power 
calculation had indicated that a total sample size of N = 42 (21 in each group) was deemed 
necessary to detect a mean difference in mindfulness skills between the treatment and the 
control group. However, whilst the final sample size fell some way short of this, nevertheless 
large effect sizes were detected at both the between- and within-groups level of analysis. 
 
4.6.2 Control group issues 
This study used a small wait-list control (WLC) group. In order to perhaps draw firmer 
conclusions in respect of the hypothesis concerning changes in self-efficacy and quality of 
life being due to changes in mindfulness skills, a usual care (UC),  larger wait-list control 
(WLC) or alternative treatment  control arm may possibly have proven equally if not more 
robust.  However it is perhaps worth noting that even in cases where an RCT design has been 
employed, only a small number of MBI trials could be deemed to be robust according to 
consolidated standards of reporting trials (CONSORT) guidelines (e.g., due to factors such as 
insufficient details for replication, an overall lack of transparency, absence of justification for 
sample sizes, etc.).  
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Whilst MBIs appear to have demonstrated much promise across an increasingly broad range 
of clinical settings and for a variety of psychological, physical and psychosomatic disorders 
and difficulties, questions do remain concerning the efficacy of such interventions. Indeed, in 
a preliminary analysis of 21 MBI studies, Baer (2003) found a mean effect size of 0.59 which, 
whilst superficially encouraging, nevertheless revealed a particular lack of methodological 
rigour in many cases.  
 
4.6.3 Possible moderating variables within the sample regarding therapeutic benefits 
Ethnicity: The sample identified itself in its entirety as White British. Whilst this is broadly 
representative of the local population from which the sample was drawn, this is certainly not 
the case for other areas in the UK, particularly large cities. This may have accounted for 
some of the group effects (i.e., participants may have experienced a sense of cohesion with 
some members identifying more readily with one another and gaining a sense of 
psychological support). An important consideration might be in terms of catering to more 
culturally or ethnically diverse groups, some of whom may have prior knowledge or 
exposure to similar practices – but this may also present a barrier to accessing such 
interventions. 
Group effects: connected to the points made above, it was difficult to ascertain to what 
extent the improvements could be attributed to the MBI alone. Another limitation is the 
possible effect of participation in a group setting, which can have therapeutic effects (Yalom 
and Leszcz, 2005). However, it is noteworthy that other MBSR studies with control groups 
have shown that MBSR has positive effects beyond those attributable to participation in a 
group setting (Davidson et al., 2003, Tacon et al., 2003). 
 
Female-to-male ratio: It is perhaps worth noting that the entirety of the first MBI group 
consisted of female participants, and it is possible that this may have impacted participants’ 
ability to engage and to relate to each other. This may have indirectly caused a response bias 
to the intervention and subsequent reported benefits as recorded within the outcome 
measures. This aspect merits further consideration in terms of how future studies might 
control for this. It is likely that with large sample sizes available, and given that the gender 
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ratio in PD, for example, is considerably more equitable, this may enable the recruitment of 
more equal numbers of male and female participants.  
Heterogeneity of sample: Given that the sample was mixed in terms of clinical presentations, 
it is perhaps important to consider individuals’ rehabilitation trajectories and management 
of their respective chronic conditions. It was not possible to predict with any accuracy 
whether participants’ physical or cognitive health might have deteriorated during the course 
of the study, and thus might account for non-attendance or attrition rates, or indeed impact 
responses to the outcome measures.  
Clinical profile of participants: Very few MBI studies adequately control for potential 
confounding factors such as concurrent psychopharmacology, concomitant psychotherapy, 
and/or illness severity (Klainin-Yobas et al., 2012). As mentioned earlier, the course of MS 
and PD in particular are variable and unpredictable at best, as are recovery trajectories for 
ABI (e.g., stroke may present a much wider variation than other injuries), hence perhaps the 
difficulty in offering  and monitoring psychological input to this client group. Also, it was 
unclear how many of the participants were on medication at the time of entering the study, 
and where this was not the case, whether their status changed during the course of the 
intervention. There may have also been a possible role due to effects and interactions of 
medication. This is an important issue to bear in mind. Given that first-line treatments for 
individuals with neurological conditions are frequently pharmacological in nature, perhaps 
the study could have included a brief questionnaire at assessment in order to ascertain the 
clinical characteristics of participants more comprehensively. 
Dose-response effects: there was an indication that higher levels of attendance translated to 
larger self-reported improvements on outcome measures. Given that the first group ran 
according to plan, and the second and third groups encountered some unexpected 
scheduling issues (e.g. during Group 2, a session was cancelled due to adverse weather 
conditions), this may have also impacted on results. This needs to be borne in mind when 
interpreting findings and considering other possible factors contributing to observed 
treatment gains or lack thereof. It may have also been useful to conduct further analysis into 
dosage effects of the group intervention (i.e. to what extent might patterns of attendance 
have reliably predicted changes in outcome measures in the expected direction concerning 
the intervention hypotheses). 
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4.6.4 Lack of screening measures and follow-up 
The lack of clinical information prior to recruitment also highlights further concerns in terms 
of the suitability of participants. The study did not adopt a specific protocol for screening 
participants in terms of their suitability for the MBI in question. Rather, it relied on the 
clinical judgements of referring professionals, which may or may not have included some 
form of clinical or neuropsychological assessment to determine this.  The lack of screening 
measures pre-baseline assessment for all participants is an important consideration to be 
borne in mind, as screening may have highlighted any specific issues around cognitive or 
other impairments which may in turn may have impacted on participants’ attendance, 
acceptability and/or reported improvements in relation to the intervention. It was also 
difficult to ascertain variations in participants’ health status as they progressed through the 
study, and whether this may have also contributed to a response bias.  
Similarly, due to time and resource constraints, it was not possible to follow participants up 
beyond the post-intervention phase in order to explore whether improvements were 
maintained over the longer term, especially since the intervention was of brief duration.  
The absence of a follow-up assessment, which appears to be increasingly used in 
mindfulness research, makes it difficult to provide a more robust interpretation of the 
encouraging findings as noted in this study.   
 
4.6.5 Format of the intervention and treatment fidelity 
The intervention evaluated in this study utilised an adapted, brief-session format which was 
loosely based on a typical MBSR programme. One possible consideration may be in respect 
of treatment fidelity (i.e., a non-manualized protocol) and duration and focus of intervention 
(4-session vs. 8-session model). Despite this study’s strong findings, the question remains as 
to whether a 4-session model  (consisting of one-hour sessions) is perhaps too brief and not 
sufficiently comprehensive for the cultivation and development of some of the more 
challenging practices which it is theorized lead to sustained clinical benefits over the longer 
term. 
A further concern relates to the variations in credibility, expertise and competence of MBI 
facilitators (Shonin et al., 2013c). Whilst referring to the stream of mindfulness teachings 
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formulated by the likes of Kabat-Zinn (i.e., the teachings currently imparted by MBI 
instructors), Cullen (2011) states that MBIs are “their own new lineage” (p.186). Lineage is 
another important concept within Buddhism and essentially refers to the “authenticity” of 
Buddhist teachers. In addition to receiving direct instruction from an accomplished 
meditation teacher, authentic Buddhist masters generally undergo decades of  daily 
focussed meditation training with the aim of relinquishing attachment to worldly concerns 
such as wealth, career or fame (Shonin et al., 2013a). This is in contrast to Western MBI 
instructors, who may have as little as a year’s mindfulness experience following completion 
of a single 8-week course (Mental Health Foundation, 2010). Therefore, claims that MBIs 
constitute an authentic lineage in the traditional Buddhist sense may be considered 
somewhat unrealistic or spurious. 
Additionally, data pertaining to participants’ reported adherence to between-session 
practice was not elicited or collected for the purposes of this study, although within the 
context of each session, participants were encouraged to explore and discuss their practice 
with the facilitator. This was obviously difficult to monitor and control for given the nature of 
the intervention and participants not necessarily being required to complete “homework” or 
reporting perhaps higher levels of practice to what might in fact have been the case.   
 
4.7 Further methodological considerations 
4.7.1 Quantitative design 
This study adopted a quantitative methodology, as this was considered a possibly more 
appropriate paradigm in which to provide more robust findings for the utility of MBIs with 
the sample population in question (Barker, Pistrang & Elliott, 2002). Moreover, the current 
quantitative research appears to have provided strong evidence for the effectiveness of 
MBIs. However, a qualitative element could perhaps have been more fully explored (e.g., 
semi-structured interviews with a selection of participants from each group,  focus groups, 
or a specifically formulated evaluation questionnaire) and may have captured participants’ 
views, experiences and perspectives on possible reasons for improvements or lack of 
perceived benefit of the MBI in question. This may have provided a richer and more subtle 
understanding of the mechanisms by which the intervention may have exerted its effects. 
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Alternatively, it may have also been useful to obtain qualitative feedback from carers or 
families in order to further elucidate and explain any findings and to shed light on perceived 
improvements from others’ perspectives rather than relying on self-report from participants 
alone. 
 
4.7.2 Selection of outcome measures 
One potential point of discussion concerns the outcome measures selected in the present 
study, and how accurately they purported to measure what they aimed to measure. During 
the last decade, there has been a number of mindfulness measures developed, with a 
considerable degree of overlap in terms of their psychometric properties. One recent 
innovation in the field of neuro-rehabilitation has been the development and validation of 
the Neuro-QOL (Cella et al., 2012), which at the time of the present study being conducted, 
was not able to be employed. Preliminary validation studies suggest that this may be a more 
sensitive psychometric tool which includes separate scales for depressive and anxiety 
symptoms. These may have been particularly useful in capturing other psychological 
variables within the sample in this study. 
 
4.7.3 Measuring mindfulness: the debate concerning psychometrics   
The selection of outcome measures in relation to the present study merits further 
consideration and discussion, both in terms of the number of measures selected and in view 
of the characteristics of the sample. A current issue of debate concerns the apparent over-
dependence in MBI studies on self-report measures, and this in itself raises further issues 
around how measurement of an ostensibly multi-dimensional construct such as mindfulness 
is possible.   
Within the mindfulness research community, considerable debate persists with respect to 
how accurately and viably generic or specific, standardised measures of mindfulness tap into 
or indeed capture constructs both concerning psychological processes and consequences of 
mindfulness. This applies to the field of ABI as well as other long-term conditions. Recent 
theoretical debates concerning psychometrics have highlighted the difficulties and confusion 
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in defining and operationalizing mindfulness, with some disagreement as to whether it 
should be regarded as a  construct reflecting a ‘trait or state’, and how this can be reflected 
in outcome measures. As Baer (2003) has noted, 
“the practice of mindfulness is concerned with the cultivation of awareness, insight, wisdom, 
and compassion, concepts that may be appreciated by many people, yet difficult to evaluate 
empirically” (p.140)  
It is also likely that the evaluation and measurement of constructs in a culture different to 
that from which these constructs have originated may represent a further limitation. In the 
relative absence of external referents to verify the validity of constructs of mindfulness used 
in self-report scales, much of the research findings based on these indirect assessments may 
pose problems in terms of validity. As has been mentioned earlier, within the traditional 
context, the term mindfulness is derived from the Pali word sati that conveys the meaning 
‘to remember’ (i.e., remembering to maintain awareness), with four distinct phases 
described in the traditional literature. This is clearly distinct from the modern attempts at 
operationalizing a fixed trait-like definition of mindfulness that ignores the developmental 
and contextual aspects of this concept (Grossman and Van Dam, 2011). Individuals with no 
meditation experience respond to the word “mindfulness” questionnaire items differently 
from people with meditation experience, as seems likely from the results of a study (using 
the MAAS), where binge drinking university students scored significantly higher scores 
compared to experienced meditators (Leigh et al., 2005).  
More such issues regarding reliability and validity of self-report questionnaires have been 
raised recently (Bergomi et al., 2012; Brown et al., 2011). In assessing all the available self-
report scales of mindfulness, Bergomi et al. (2012) reported that these scales do not offer a 
comprehensive assessment of all aspects of mindfulness in samples from the general 
population. Similarly, Chiesa (2012) has asserted that modern attempts to operationalize 
mindfulness have consistently failed to provide a universally agreed, unequivocal definition 
of mindfulness that takes into account the complexity of the original traditional definitions 
of the term.  
According to Grossman (2011), currently used self-report measures of mindfulness may in 
fact reduce, obscure and distort the meaning of “mindful awareness” in psychological 
sciences and research. Consequently, this could negatively impact the possibility of further 
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development of MBIs and their possible adaptations with specific clinical populations. A 
study by Höfling et al. (2011) which evaluated the construct validity of the MAAS by 
developing a short version of this instrument by including positively worded items, found 
that it is important to control for method effects due to item wording. This would appear to 
challenge Brown and Ryan’s (2003) assertion that an assessment of “mindlessness” via only 
negatively worded items on the MAAS is empirically equivalent to mindfulness. One of the 
possible implications of this in terms of the present study might be that the wording of items 
may have induced a response bias in participants however the findings do not appear to 
have borne this out.  
 
4.7.4 Defining mindfulness 
Grossman (2011) has further queried whether self-report measures actually assess 
mindfulness, or whether the construct of mindfulness can be understood apart from 
mindfulness training, and whether there is empirical evidence to support the validity of 
mindfulness measures. In response to these criticisms, Brown et al. (2011) have discussed an 
established theory that attention (and secondarily meta-awareness) is core to the meaning 
of mindfulness. They further posit that it is the central feature of the MAAS and argue that 
mindfulness is an inherent capacity that varies between and within individuals. This view 
would appear to contradict Grossman’s claims that mindfulness is a concept applicable to 
only a trained few. Furthermore, as assessed by the MAAS, mindfulness is associated with 
the same variety of outcomes as mindfulness training is theorized to produce. Brown and 
colleagues provide evidence that the MAAS is a valid instrument, concluding that although 
construct measurement is inevitably imperfect, such efforts are critical to building basic 
knowledge bases and tailoring or refining effective interventions across a range of clinical 
presentations and groups. 
 
Whilst meditation and mindfulness interventions are often promoted as a means of reducing 
stress, enhancing psychological and mental well-being, and even managing physical 
ailments, it remains difficult to ascertain whether the techniques per se promoted within 
MBIs actually bring about the predicted outcomes researchers may propose. A meta-analysis 
by Eberth and Sedlmeier (2012) found large differences in effect sizes reported for MBSR 
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compared with mindfulness meditation, arguing that these effects might feasibly be 
attributed to other factors such as differences between groups, participants’ expectations or 
psycho-education. Moreover, the emphasis between the interventions in terms of specific 
mindfulness practices may also have varied considerably.  
Travis (2011) explored if psychological well-being and mindfulness are related to the type of 
meditation technique practiced and argued that it was difficult to interpret findings between 
different groups due to large demographic and process differences. In a recent meta-
analysis, Sedlmeier et al. (2012) provided a comprehensive overview of the effects of 
meditation on psychological variables in non-clinical groups of adult meditators. The authors 
identified several methodological problems in a large number of studies and reported a lack 
of sufficient theoretical background in most studies. They examined 21 separate categories 
of dependent measures in a large number of meditation research reports and found that in 
general, meditation did not exert uniform effects on the categories of dependent measures 
examined. The authors compared meditation with relaxation response and cognitive training 
and concluded that in their opinion meditation is not merely a relaxation technique. Instead, 
they found that meditation has a substantial impact on psychological variables, and these 
effects would appear to be stronger for emotional than for cognitive variables. 
Sedlmeier and colleagues also argue that the current state of theories on meditation and 
mindfulness does not enable researchers to derive very specific hypotheses, at least not for 
the majority of the dependent measures that have been studied in the research to date. 
They assert that in the absence of a clear theoretical basis for mindfulness, alternative 
explanations may appear to overshadow the veracity and reliability of the results. Since to 
an extent, the dependent measures examined in the vast majority of studies still lack 
precision, future researchers may find it useful to explore the respective effects whilst being 
aware of differences in the various techniques being studied. In the pursuit of measuring 
psycho-physical and neural correlates of meditation, the psychological, physiological, and 
behavioural measures currently employed by researchers may not be specific to the 
particular meditation or mindfulness sub-type. 
Arguably an important concern in respect of this debate may be to the possible ethical 
implications for patients. If, unbeknownst to patients, MBIs are in fact attempting to teach 
Buddhism in what may be viewed as a ‘reconstituted’ form within healthcare settings, then 
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it would seem imperative to make this absolutely clear. Alternatively, given that MBIs claim 
a particular basis in Buddhist philosophy, if their primary intention is geared toward 
improving individuals’ psychosomatic well-being, then perhaps there is still a need for clarity 
regarding what is actually implied by this basis. In other words, patients accessing MBI 
programmes should be made aware that mindfulness as currently operationalized in MBIs 
and the associated literature is by no means congruent with the traditional Buddhist 
perspective.  
 
4.7.5 The question of specially tailored or adapted MBIs with neurological populations  
The ongoing debate concerning whether all MBIs are necessarily the same also raises 
important issues regarding  what particular considerations might feasibly need to be borne 
in mind when working with a population such as the one studied in the context of the 
present study. It is perhaps worth noting that an emphasis on less physically demanding 
practices may be more beneficial for ABI and neurological patients, but the question remains 
as to whether this might also paradoxically detract from the effectiveness of an MBI, if of 
course one of the major aims of these interventions is to alleviate symptoms of distress on a 
physical as well as a psychological level.  
Again, this seems linked to the idea that the validity of the collective findings of MBI studies 
is perhaps somewhat restricted by a certain heterogeneity in how different MBIs 
conceptualize mindfulness as well as differences in MBI programme design (e.g., variations 
in programme length, duration of weekly sessions, quantity of psycho-education, amount of 
physical exercise/yoga, focus on different aspects of practice over others, etc.).For example, 
a recent meta-analysis by Vøllestad et al. (2012) incorporated seven different MBIs in which 
the total number of sessions ranged from 8 to 16, and the duration of individual sessions 
varied between 45 and 150 minutes (the standard duration being 120 minutes per session). 
There is a suggestion (and an ostensibly increasing empirical evidence base) that MBI-related 
clinical benefits are associated with the length, duration and amount of practice in which an 
individual engages with mindfulness. The underlying hypothesis is that regular, sustained 
practice is predictive of larger beneficial effects, although it is perhaps questionable that 
mere length or regularity of practice necessarily brings about these benefits as opposed to 
depth of mindfulness experience. 
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4.8 Possible future developments and directions for research 
The collective body of literature examining MBIs in relation to this particular population 
remains limited and to an extent, in its infancy. As such, it only includes very few studies 
looking at MBI for this population. Moreover, the research tends to be mainly focussed on 
ABI and TBI, with more recent studies looking at discrete neurological conditions such as MS 
or PD. It would seem that more research is needed in the area, especially given the relatively 
high prevalence and incidence of neurological conditions and their potential burden on 
services.  
From a methodological perspective, the adoption of more rigorous RCT designs, with some 
thought as to the exploration of a range of appropriate control arms would be welcomed 
(e.g., MBI vs. Treatment As Usual [TAU], MBI vs. CBT, MBI vs. other types of attentional 
training, MBI vs. CFT or ACT, both of which emphasise themes around acceptance and non-
judgmental appraisal of one’s circumstances). Alongside this, it would seem important to 
consider the development of longitudinal studies with an option for longer-term follow-up 
periods post-intervention. This further points to the need to employ longer timescales, 
recruit larger samples and adopt more powerful research designs before firmer conclusions 
may be drawn as to the efficacy of MBIs. 
There is preliminary evidence to suggest the effectiveness and utility of manualized MBI 
programmes with neurological patients, although very little research has evaluated this with 
a mixed population. There is therefore scope for continued research in this area, both 
employing the traditional MBSR approach as well as perhaps considering other MBI formats 
such as MBCT, ACT or elements of CFT, as in the work of Wilson et al. (2013). These may 
emphasise aspects of mindfulness which may be deemed particularly suitable or pertinent to 
ABI and neurological populations. There is a further possibility that the encouraging findings 
of the present study could be replicated with other client groups who may exhibit similar 
difficulties. One possible application of this adapted model of MBI might be targeted for 
individuals with mild cognitive impairment or other chronic health conditions.  
 
Given that the majority of MBIs tend to be delivered in group formats, Dimidjian and 
Linehan (2003) have posited that it may be important for future research to address whether 
the group setting and format for MBIs (in particular, MBSR and MBCT manualized 
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programmes) is an essential part of mindfulness skills training within clinical contexts, and 
this would certainly seem an important consideration within the field of neurorehabilitation. 
If so, it may also be useful to consider whether MBIs are able to be effectively incorporated 
or integrated into individual psychological interventions for this population (see Hofer et al., 
[2014] for a recent adaptation incorporating elements of mindfulness with stroke patients).  
 
As Awasthi (2012) has recently asserted, attempts to include a more phenomenological 
account of mindfulness (and meditation in general) may help determine and formulate a 
clear and operational definition for developing future research. In agreement with Lutz and 
Thompson (2003), he proposes that one possible avenue might involve the adoption of a 
more neuro-phenomenological approach that can be used to guide the study of 
physiological processes. An integration of traditional ontology, first-person, qualitative 
phenomenological reports and neuroscientific evidence will perhaps enable the 
development of more comprehensive models of the mind to help find common ground for 
scientific research with the contemplative traditions. 
 
4.9 Conclusions  
There are a number of conclusions which may be drawn from this study. In the first instance, 
the present study appears to have demonstrated the feasibility of running a brief, suitably 
modified MBI programme for a mixed population of patients with an ABI or neurological 
condition. Secondly, the study has also provide encouraging results in terms of the potential 
effectiveness of an adapted MBI with this population, particularly with regards to 
mindfulness training effects, and would appear to point to increased mindfulness skills 
exerting positive effects in terms of individuals’ reported self-efficacy (specifically, a capacity 
to regulate emotions and to take responsibility for their reactions to their difficulties) and 
health-related quality of life. Thirdly, the moderate to large effect sizes observed appeared 
to support these findings convincingly and provide further evidence for the effectiveness of 
an MBI for this population. 
One of the strengths of this study was the use of a representative sample and the 
naturalistic setting in which it was conducted. In addition to this, the study is one of the first 
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to attempt to explore the mechanisms of mindfulness within a mixed clinical population, and 
one of the first to report data on outcome measures such as the MSES-R and PQoL within 
this group. However, the study had several limitations, which may have contributed to some 
of the less promising findings. These included a small sample size and multiple comparisons, 
a purely quantitative design, the lack of a follow-up assessment, and an over-reliance on 
self-report measures. Whilst it could be argued that the study did not allow firm conclusions 
to be drawn regarding observed changes in being directly attributable to mindfulness per se, 
and some thought should be given to the selection of psychometric instruments in terms of 
conceptualizing and operationalizing mindfulness as a definable construct, it will be 
important for future research to address these methodological issues. 
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Appendix 2: Mindfulness diary (sample) 
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Appendix 3:  Outcome measures 
Primary outcome measures:  FMI 
    MAAS 
Secondary outcome measures: MSES-R 
    PQoL* 
 
*NB: the Perceived Quality of Life Scale (PQoL) measure has not been included due to 
copyright protection. Details regarding seeking permission to access and use the PQoL, are 
available at: http://depts.washington.edu/seaqol/PQOL 
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Freiburg Mindfulness Inventory  
 
 
Description:  
 
 
The FMI is a useful, valid and reliable questionnaire for measuring mindfulness. It is 
most suitable in generalized contexts, where knowledge of the Buddhist background of 
mindfulness cannot be expected. The 14 items cover all aspects of mindfulness.  
 
 
 
The purpose of this inventory is to characterize your experience of mindfulness. Please  
use the last ___ days as the time-frame to consider each item. Provide an answer for every 
statement as best you can. Please answer as honestly and spontaneously as  
possible. There are neither „right‟ nor „wrong‟ answers, nor „good‟ or „bad‟ responses.  
What is important to us is your own personal experience.  
 
    1    2    3    4  
Rarely                  Occasionally                  Fairly often                   Almost always  
 
 
I am open to the experience of the present moment.   1          2          3          4  
 
I sense my body, whether eating, cooking, cleaning or  
talking.        1          2          3          4 
 
When I notice an absence of mind, I gently return to  
the experience of the here and now.     1          2          3          4 
 
I am able to appreciate myself.     1          2          3          4  
 
I pay attention to what‟s behind my actions.    1          2          3          4  
 
I see my mistakes and difficulties without judging them.  1          2          3          4  
 
I feel connected to my experience in the here-and-now.  1          2          3          4  
 
I accept unpleasant experiences.     1          2          3          4  
 
I am friendly to myself when things go wrong.   1          2          3          4  
 
I watch my feelings without getting lost in them.   1          2          3          4  
 
In difficult situations, I can pause without immediately  1          2          3          4  
reacting.  
 
I experience moments of inner peace and ease, even  
when things get hectic and stressful.     1          2          3          4 
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I am impatient with myself and with others.    1          2          3           4  
 
I am able to smile when I notice how I sometimes make  1          2          3           4  
life difficult.  
 
 
Scoring Information:  
 
Add up all items to get one summary score. When scoring, please observe that there are a 
couple of reversed items. For these you need to reverse the scoring, preferably by a 
recode command that recodes 1 into 4, 2 into 3, 3 into 2 and 4 into 1.  
 
The item to be recoded is “I am impatient with myself and with others.”  
 
At the moment, we do not recommend to use separate factor-scale scores. If you wish to 
do so, we recommend that you analyze your own data set and extract 4 to 6 factors 
according to the data structure you find and then proceed accordingly, adding up item 
scores per scale.  
 
 
Reference:  
Walach, H., Buchheld, N., Buttenmuller, V., Kleinknecht, N., Schmidt, S. (2006).  
Measuring Mindfulness--The Freiburg Mindfulness Inventory (FMI). Personality  
            and Individual Differences, 40, 1543-1555. 
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Day-to-Day Experiences 
 
Instructions: Below is a collection of statements about your everyday experience. 
Using the 1-6 scale below, please indicate how frequently or infrequently you 
currently have each experience. Please answer according to what really reflects 
your experience rather than what you think your experience should be. Please 
treat each item separately from every other item.  
 
1           2                   3                    4                         5              6 
      Almost            Very           Somewhat          Somewhat              Very               Almost 
      Always          Frequently    Frequently        Infrequently        Infrequently          Never 
 
 
I could be experiencing some emotion and not be conscious  
of it until some time later.      1      2       3      4      5      6 
 
I break or spill things because of carelessness, not paying 
attention, or thinking of something else.    1      2       3      4      5      6 
 
I find it difficult to stay focused on what‟s happening in  
the present.        1      2       3      4      5      6 
 
I tend to walk quickly to get where I‟m going without  
paying attention to what I experience along the way.   1      2       3      4      5      6 
 
I tend not to notice feelings of physical tension or  
discomfort until they really grab my attention.   1      2       3      4      5      6 
 
I forget a person‟s name almost as soon as I‟ve been told it 
for the first time.       1      2       3      4      5      6 
 
It seems I am “running on automatic,” without much  
awareness of what I‟m doing.      1      2       3      4      5      6 
 
I rush through activities without being really attentive to  
them.         1      2       3      4      5      6 
 
I get so focused on the goal I want to achieve that I lose  
touch with what I‟m doing right now to get there.              1      2       3      4      5      6 
 
I do jobs or tasks automatically, without being aware of  
What I'm doing.       1      2       3      4      5      6 
 
I find myself listening to someone with one ear, doing 
something else at the same time.     1      2       3      4      5      6 
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1           2                   3                    4                         5              6 
      Almost            Very           Somewhat          Somewhat              Very               Almost 
      Always          Frequently    Frequently        Infrequently        Infrequently          Never 
 
 
 
I drive places on „automatic pilot‟ and then wonder why I  
went there.        1     2      3      4      5        6 
 
I find myself preoccupied with the future or the past.   1     2      3      4      5        6 
 
I find myself doing things without paying attention.   1     2      3      4      5        6 
 
I snack without being aware that I‟m eating.    1     2      3      4      5        6 
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Mindfulness-Based Self Efficacy Scale - Revised
©
 (MSES-R) 
         Bruno A. Cayoun, 
MiCBT Institute & University of Tasmania 
 
NAME…………………........……… DATE…………... Session/Week No.….…… 
  
Circle one number in the shaded column according to how much you now agree with each 
statement below, using the following scale: 
 
Not at all  A little              Moderately   A lot             Completely 
      0       1            2       3                   4 
 
Try not to spend too much time on any one item. There are no right or wrong answers. 
1. I get easily overwhelmed by my emotions 0 1 2 3 4 
2. I find it difficult to make new friends 0 1 2 3 4 
3. I try to avoid uncomfortable situations even when they are really important 0 1 2 3 4 
4. When I feel very emotional, it takes a long time for it to pass 0 1 2 3 4 
5. I feel comfortable saying sorry when I feel I am in the wrong 0 1 2 3 4 
6. It is often too late when I realise I overreacted in a stressful situation 0 1 2 3 4 
7. I get so caught up in my thoughts that I end up feeling very sad or anxious 0 1 2 3 4 
8. When I have unpleasant feelings in my body, I prefer to push them away 0 1 2 3 4 
9. I can resolve problems easily with my partner (or best friend if single) 0 1 2 3 4 
10. I can face my thoughts, even if they are unpleasant 0 1 2 3 4 
11. My actions are often controlled by other people or circumstances 0 1 2 3 4 
12. I get caught up in unpleasant memories or anxious thoughts about the future 0 1 2 3 4 
13. I can deal with physical discomfort 0 1 2 3 4 
14. I feel I cannot love anyone 0 1 2 3 4 
15. I am often in conflict with one (or more) family member 0 1 2 3 4 
16. I avoid feeling my body when there is pain or other discomfort 0 1 2 3 4 
17. I do things that make me feel good straightaway even if I will feel bad later 0 1 2 3 4 
18. When I have a problem, I tend to believe it will ruin my whole life 0 1 2 3 4 
19. When I feel physical discomfort, I relax because I know it will pass 0 1 2 3 4 
20. I can feel comfortable around people 0 1 2 3 4 
21. Seeing or hearing someone with strong emotions is unbearable to me 0 1 2 3 4 
22. If I get angry or anxious, it is generally because of others 0 1 2 3 4 
If you use(d) the Internet automated scoring, what is the 4-character CODE given to 
you?:……..…. 
Copyright © 2004-2011 Bruno A. Cayoun. May be reproduced for clinical and research purposes. 
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Appendix 4:  Feedback evaluation form 
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MINDFULNESS MEDITATION GROUP FEEDBACK FORM 
We are always looking for ways to improve our Service, and we would be grateful if you could find the 
time to answer the following questions on the services you have received. 
1) I could easily understand the information presented in the group 
Strongly agree  □ 
Agree   □ 
Neutral   □ 
Disagree  □ 
Strongly disagree □ 
2) I was happy with the number of group sessions  
Strongly agree  □ 
Agree   □ 
Neutral   □ 
Disagree  □ 
Strongly disagree □ 
3) The sessions were long enough, i.e. an hour 
Strongly agree  □ 
Agree   □ 
Neutral   □ 
Disagree  □ 
Strongly disagree □ 
4) I have learnt more about mindfulness meditation in this group 
Strongly agree  □ 
Agree   □ 
Neutral   □ 
Disagree  □ 
Strongly disagree □ 
5) I have learnt more about ways to cope with my problems in my day-to-day life 
through mindfulness meditation 
Strongly agree  □ 
Agree   □ 
Neutral   □ 
Disagree  □ 
Strongly disagree □ 
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6) I found it helpful being with other people when learning this meditation technique 
Strongly agree  □ 
Agree   □ 
Neutral   □ 
Disagree  □ 
Strongly disagree □ 
7) I feel more positive about coping with my day-to-day difficulties following the 
meditation group 
Strongly agree  □ 
Agree   □ 
Neutral   □ 
Disagree  □ 
Strongly disagree □ 
 
8) I feel less anxious after having learnt mindfulness meditation 
Strongly agree  □ 
Agree   □ 
Neutral   □ 
Disagree  □ 
Strongly disagree □ 
 
9) I feel less depressed after having learnt mindfulness meditation 
Strongly agree  □ 
Agree   □ 
Neutral   □ 
Disagree  □ 
Strongly disagree □ 
 
10) I feel less angry after having learnt mindfulness meditation 
Strongly agree  □ 
Agree   □ 
Neutral   □ 
Disagree  □ 
Strongly disagree □ 
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Any other feedback: 
 
 
 
 
 
 
 
 
 
Thank you! 
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Appendix 5:  Participant information sheet/Letter of invitation 
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PARTICIPANT INFORMATION SHEET 
Be Here Now: A study looking at a mindfulness-based group for people with an acquired 
brain injury (ABI) or neurological condition 
University of Hertfordshire/Hertfordshire Neurological Service (Hertfordshire Community 
NHS Trust) 
What is this study about? 
Research has shown that coping with the difficult emotions, lifestyle changes and symptoms 
associated with acquired brain injury (or ABI) and neurological conditions can be challenging 
for a lot of people. Many patients with ABI experience periods of feeling down, distressed 
and/or anxious and find it difficult to manage these feelings and adjust to life after an ABI. 
Mindfulness is a set of simple techniques which helps with distressing emotions. It’s a way 
of paying attention to the present, using simple meditation and relaxation techniques such 
as focused breathing that help people become more aware of their feelings. Research shows 
that when people practice these they are able to manage their difficulties better. In this 
study we would like to find out whether a short, specially adapted mindfulness group 
programme currently being offered to ABI patients in Hertfordshire can be helpful for 
people who report difficulties with managing their feelings, and also help improve their 
quality of life after injury. We would like to invite you to take part in this study. 
 
Who is conducting the research? 
This study is part of a Clinical Psychology Doctorate led by Ross Canadé (Trainee Clinical 
Psychologist). It is being supervised by Mr Joerg Schulz (Senior Lecturer in Research 
Methods & Statistics) at the University of Hertfordshire, and Mr Daniel Friedland 
(Consultant Clinical Neuropsychologist) at Jacketts Field Neurological Centre (Hertfordshire 
Neurological Service).  
 
How will this help people affected by ABI and neurological conditions? 
We cannot promise the study will help you, but the evidence so far is showing more and 
more that mindfulness-based programmes are very helpful for people with chronic 
conditions (including those who have suffered a brain injury) in coping with some common 
difficulties and adjusting to their life. We hope that the information we get as a result of this 
study will help us make the programme more relevant to the needs of people with ABI. 
Because it is a shorter programme than usual, if our results show it does help people, we 
hope it will be able to be offered to more patients than is currently the case. 
 
What will happen during the study? 
We will ask you whether you would like to take part in the study. If you agree to take part,   
we will then allocate you to either the mindfulness group or a waiting list group. This means 
that some of you will start the course very soon after you’ve agreed to take part. Some of 
you may have to wait for a few weeks before you start. However, all of you will have the 
opportunity to be in the group at some point. The mindfulness course will consist of 4 one-
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hour sessions (i.e. one mindfulness session per week). Each session lasts only one hour. The 
course will be delivered in a group format. We expect that there will be around 6-8 people 
to each group. The group is facilitated by a clinical psychologist who has a lot of experience 
in teaching and practising mindfulness techniques, and who has worked for a number of 
years with ABI patients. 
As part of the programme, we will ask you to practice mindfulness meditation and the 
techniques regularly between sessions. In order to find out whether the programme is 
helping, we will also ask you to fill in 4 -5 short questionnaires at three points:  
 before you start the group;  
 when the group finishes;  
 3 months after the group has finished.  
These questionnaires should take about 40-45 minutes to complete. Somebody will be with 
you to help complete these. At the end of the programme, we will ask you to feed back 
about your experiences and views about the mindfulness sessions.  
 
Why are you being invited to take part in this study? 
You have been invited to take part in this study because: 
 you have an acquired brain injury (ABI) or neurological condition; 
 you have been identified as someone who may benefit from a mindfulness-based group and 
are already on a waiting list for the group; 
 you have NOT received any formal training in mindfulness methods before; 
 you are NOT currently receiving any other psychological treatment; 
 you do NOT have serious problems with concentration; 
 you are NOT highly distressed. 
 
When can I take part in this study? 
We expect that you will be able to take part in the study from October 2013 - May 2014. 
 
Time Commitment 
The group typically takes an hour per session over 4 sessions. The group takes place once a 
week, so you will finish the group after 4 weeks. The questionnaires we will ask you to 
complete are relatively straightforward and take around 40-45 minutes of your time. We 
hope that we can arrange for you to complete these at a convenient time for you. 
 
Participants’ Rights 
You may decide to stop being a part of the research study at any time without explanation. 
You have the right to ask that any data you have supplied to that point be withdrawn or 
destroyed. You have the right to omit or refuse to answer or respond to any question that is 
asked of you without penalty. 
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You have the right to have your questions about the procedures answered (unless 
answering these questions would interfere with the study’s outcome). If you have any 
questions as a result of reading this information sheet, you should ask the researcher before 
the study begins. 
We think it is important to let your GP know that you are taking part in the study, so we will 
be writing to your GP to inform them of this.  
 
Confidentiality 
If you agree to take part, your name will not be recorded on any of the questionnaires and 
the information will not be disclosed to other parties. Your responses to the questionnaires 
will be used for the purpose of this study only. We will not have access to any of your 
medical records. You can be assured that if you take part in the study you will remain 
anonymous. When the data we have collected is analysed, it will remain anonymous. 
 
Benefits and Risks 
There are no known benefits or risks for you in this study. However, people who have been 
involved in previous mindfulness groups have said that they have found some of the 
techniques very helpful in managing with life after ABI or a neurological condition. They 
have also said that they enjoy being in a group.  
 
Where is this research taking place? 
This research is taking place at the University of Hertfordshire, Hatfield and the 
Hertfordshire Neurological Service.  
 
Will you inform me of the results of the study? 
Yes. When we have completed the study we will produce a summary of the findings which 
we will be more than happy to send to you if you are interested. 
 
Interested? 
If you are interested in taking part, or would like to find out more about this study or discuss 
anything in more detail, please contact Ross at r.f.canade@herts.ac.uk or call 01923 299124. 
Please note that enquiring about participation does not commit you in any way. If you 
decide you would rather not participate in this study, simply ignore this letter and no further 
contact will be made. If you would like to take part, please complete the enclosed consent 
form and return in the pre-addressed envelope provided within 10 days of receipt of this 
letter.  
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Appendix 6:  Consent form 
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Centre Number:  
Study Number:  
Patient Identification Number for this trial: 
INFORMED CONSENT FORM 
Title of Project:  Be Here Now: A study looking at a mindfulness-based group for people 
with an acquired brain injury (ABI) or neurological condition 
Name of Researcher:  Ross Canadé 
Please initial all boxes  
1. I confirm that I have read and understand the information sheet dated 17/10/2013, 
version 4 for the above study.  I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time without giving any reason, without my medical care or legal rights being affected. 
3. I understand that relevant sections of my medical notes and data collected during the 
study, may be looked at by individuals from Hertfordshire Neurological Service, from 
regulatory authorities or from the NHS Trust, where it is relevant to my taking part in 
this research.  I give permission for these individuals to have access to my records. 
4. I agree to my GP being informed of my participation in the study.    
 
5. I agree to take part in the above study.    
 
 
 
   __         __ 
Name of Participant   Date    Signature 
                    
   __         __ 
Name of Person taking consent  Date    Signature  
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Be Here Now: A study looking at a mindfulness-based group for people with an acquired 
brain injury (ABI) or neurological condition 
University of Hertfordshire/Hertfordshire Neurological Service (Hertfordshire Community 
NHS Trust) 
Dear Dr (Name), 
(GP Surgery) 
Re: Patient name 
Date of birth: D.O.B 
 
I am currently conducting a research study as part of my Doctorate in Clinical Psychology. 
This study will evaluate the effectiveness of a mindfulness-based group intervention for 
people with an ABI or neurological condition. This psychological intervention is currently 
being offered to some ABI patients as part of their standard rehabilitation within 
Hertfordshire Neurological Service. The study is a randomised trial, with some patients 
receiving the intervention at an earlier stage than others. For further information, please 
refer to the enclosed participant information sheet. Your patient, (patient name), has agreed 
to take part in the study.   
The study will involve administering a set of brief questionnaires at various time points. The 
questionnaires will consist of measures asking about mindfulness skills and patients’ health-
related quality of life. We will also ask participants for feedback about the group 
programme. These will be administered at Jacketts Field Neurological Centre wherever 
possible. We hope that the results of this study will  demonstrate the usefulness of this 
intervention in patients’ care.  
It is expected that participants will be involved in the study for approximately 4 months. We 
do not anticipate that any aspects of the study will interfere with your patient’s usual 
treatment. If you would like any further information about this project, please do not 
hesitate to contact me using the details above. 
 
Yours sincerely, 
 
Ross Canadé 
Trainee Clinical Psychologist/Principal Investigator 
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Appendix 9:  Mann-Whitney U non-parametric test output 
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Mann-Whitney Test 
Ranks 
 
Group N Mean Rank Sum of Ranks 
FMI 
1 7 8.86 62.00 
3 6 4.83 29.00 
Total 13 
  
MAAS 
1 7 7.64 53.50 
3 6 6.25 37.50 
Total 13 
  
PQOL 
1 7 8.14 57.00 
3 6 5.67 34.00 
Total 13 
  
TS_MSES_ER 
1 7 9.00 63.00 
3 6 4.67 28.00 
Total 13 
  
TS_MSES_EQ 
1 7 8.71 61.00 
3 6 5.00 30.00 
Total 13 
  
TS_MSES_SS 
1 7 8.14 57.00 
3 6 5.67 34.00 
Total 13 
  
TS_MSES_DT 
1 7 7.79 54.50 
3 6 6.08 36.50 
Total 13 
  
TS_MSES_TR 
1 7 9.36 65.50 
3 6 4.25 25.50 
Total 13 
  
TS_MSES_IE 
1 7 7.14 50.00 
3 6 6.83 41.00 
Total 13 
  
 
Test Statistics
a
 
 
FMI MAAS PQOL TS_MSES_ER TS_MSES_EQ TS_MSES_SS TS_MSES_DT TS_MSES_TR TS_MSES_IE 
Mann-Whitney U 8.000 16.500 13.000 7.000 9.000 13.000 15.500 4.500 20.000 
Wilcoxon W 29.000 37.500 34.000 28.000 30.000 34.000 36.500 25.500 41.000 
Z -1.870 -.645 -1.144 -2.011 -1.766 -1.157 -.791 -2.428 -.147 
Asymp. Sig. (2-tailed) .061 .519 .252 .044 .077 .247 .429 .015 .883 
Exact Sig. [2*(1-tailed 
Sig.)] 
.073
b
 .534
b
 .295
b
 .051
b
 .101
b
 .295
b
 .445
b
 .014
b
 .945
b
 
a. Grouping Variable: Group 
b. Not corrected for ties. 
 
